http://pharmadispatch.com/news/documents-reveal-central-agency-assault-on-the-industrys-entitle 2024-01-08T12:00:01+11:00 http://pharmadispatch.com/news/specialised-therapeutics-signs-agreement-for-distribution-and-co 2024-01-08T12:34:01+11:00 http://pharmadispatch.com/news/bristol-myers-squibb-announces-new-general-manager-for-australia 2024-01-08T12:42:01+11:00 http://pharmadispatch.com/news/cabinet-documents-reveal-health-departments-increasing-urgency-o 2024-01-15T07:00:01+11:00 http://pharmadispatch.com/news/the-individual-numbers-are-meaningless-but-they-still-tell-a-sto 2024-01-15T10:00:01+11:00 http://pharmadispatch.com/news/why-the-failure-of-a-hard-won-process-reveals-so-much-about-an-i 2024-01-17T09:35:01+11:00 http://pharmadispatch.com/news/boehringer-ingelheim-wins-recognition-as-top-employer-for-2024 2024-01-19T08:53:01+11:00 http://pharmadispatch.com/news/gilead-partners-to-launch-grant-to-champion-health-solutions-for 2024-01-19T16:34:01+11:00 http://pharmadispatch.com/news/remember-when-the-government-spent-almost-20-years-compensating- 2024-01-22T14:00:01+11:00 http://pharmadispatch.com/news/the-other-reason-60-day-prescriptions-must-have-been-irresistibl 2024-01-22T14:00:01+11:00 http://pharmadispatch.com/news/australian-company-to-progress-peanut-allergy-candidate-to-late- 2024-01-22T14:00:01+11:00 http://pharmadispatch.com/news/its-one-of-the-first-reimbursements-and-listings-anywhere-in-the 2024-01-22T14:00:01+11:00 http://pharmadispatch.com/news/in-such-an-important-year-it-is-worth-understanding-who-will-be- 2024-01-23T14:00:01+11:00 http://pharmadispatch.com/news/tga-revokes-permission-and-bans-advertising-of-nicotine-vaping-p 2024-01-23T14:00:01+11:00 http://pharmadispatch.com/news/still-time-for-stakeholders-to-submit-to-anaos-pbs-performance-a 2024-01-23T14:00:01+11:00 http://pharmadispatch.com/news/the-need-for-genuine-transparency-in-a-system-that-markets-outco 2024-01-24T14:00:01+11:00 http://pharmadispatch.com/news/actual-growth-could-around-one-quarter-of-the-top-line-number 2024-01-24T14:00:01+11:00 http://pharmadispatch.com/news/are-healthcare-professionals-wanting-a-return-to-in-person-medic 2024-01-24T14:00:01+11:00 http://pharmadispatch.com/news/hta-review-options-paper-proposes-feedback-loop-for-patients 2024-01-29T14:00:01+11:00 http://pharmadispatch.com/news/scope-of-practice-review-issues-paper-suggests-the-reform-of-pay 2024-01-24T23:10:01+11:00 http://pharmadispatch.com/news/when-it-comes-to-the-options-paper-what-matters-is-the-detail-no 2024-01-25T14:00:01+11:00 http://pharmadispatch.com/news/novartis-venture-fund-backs-australian-companys-development-of-a 2024-01-25T14:00:01+11:00 http://pharmadispatch.com/news/medicines-australia-says-the-devil-is-in-the-detail-of-hta-revie 2024-01-29T14:00:01+11:00 http://pharmadispatch.com/news/a-radical-reworking-of-decision-making-in-the-governments-favour 2024-01-29T02:00:01+11:00 http://pharmadispatch.com/news/committee-defers-an-outcome-on-immunotherapies-but-says-it-would 2024-01-29T14:00:01+11:00 http://pharmadispatch.com/news/this-is-not-a-messaging-campaign-and-it-needs-to-be-taken-seriou 2024-01-30T14:00:01+11:00 http://pharmadispatch.com/news/medicinal-cannabis-sales-skyrocket-to-165m-in-2023-a-60-surge-re 2024-01-30T14:00:01+11:00 http://pharmadispatch.com/news/shadow-minister-challenges-butler-over-vaccine-rollout 2024-01-30T14:00:01+11:00 http://pharmadispatch.com/news/just-further-evidence-of-how-ideas-linger-waiting-for-the-right- 2024-01-31T14:00:01+11:00 http://pharmadispatch.com/news/commercial-eyes-joins-global-network-after-acquisition-by-produc 2024-01-31T14:00:01+11:00 http://pharmadispatch.com/news/pharmac-minister-says-kiwis-need-access-like-its-a-first-world-c 2024-01-31T14:00:01+11:00 http://pharmadispatch.com/news/just-further-evidence-of-how-ideas-linger-waiting-for-the-right- 2024-01-31T14:00:01+11:00 http://pharmadispatch.com/news/lilly-says-no-based-on-current-policy-the-new-proposals-would-ma 2024-02-01T14:00:01+11:00 http://pharmadispatch.com/news/if-it-is-necessary-for-me-to-formally-dissent-in-the-final-repor 2024-02-01T14:00:01+11:00 http://pharmadispatch.com/news/csl-seqirus-confirms-availability-of-cell-based-flu-vaccine-for- 2024-02-01T14:00:01+11:00 http://pharmadispatch.com/news/a-new-formulation-of-biogens-ms-therapy-eases-the-way-for-patien 2024-02-01T14:00:01+11:00 http://pharmadispatch.com/news/the-industry-will-need-to-construct-a-new-capability-to-manage-t 2024-02-02T14:00:01+11:00 http://pharmadispatch.com/news/stakeholder-concern-over-timing-of-chemotherapy-review-update 2024-02-02T14:00:01+11:00 http://pharmadispatch.com/news/thank-you-to-everyone-who-works-in-the-health-sector-and-the-pat 2024-02-02T14:00:01+11:00 http://pharmadispatch.com/news/ausbiotech-and-ma-announce-cell-gene-catalyst-working-group-memb 2024-02-02T14:00:01+11:00 http://pharmadispatch.com/news/the-week-in-review-podcast-2-february 2024-02-02T21:21:01+11:00 http://pharmadispatch.com/news/ideas-dont-appear-out-of-nowhere-and-companies-will-be-pressured 2024-02-05T15:00:01+11:00 http://pharmadispatch.com/news/companies-notified-of-planned-price-reductions-under-new-us-gove 2024-02-05T14:00:01+11:00 http://pharmadispatch.com/news/the-industry-race-is-on-as-hundreds-prepare-for-kosi-challenge 2024-02-13T14:00:01+11:00 http://pharmadispatch.com/news/nzs-cancer-society-wants-new-condition-imposed-on-pharmac-decisi 2024-02-05T14:00:01+11:00 http://pharmadispatch.com/news/this-is-what-accelerated-access-actually-looks-like-when-a-minis 2024-02-05T14:00:01+11:00 http://pharmadispatch.com/news/turnaround-for-uk-labour-with-plan-to-reverse-the-industrys-decl 2024-02-06T14:00:01+11:00 http://pharmadispatch.com/news/a-broader-assessment-of-value-would-increase-the-cost-and-reduce 2024-02-06T14:00:01+11:00 http://pharmadispatch.com/news/bioxyne-secures-australias-first-gmp-license-for-psilocybin-and- 2024-02-05T22:20:01+11:00 http://pharmadispatch.com/news/fivephusion-says-deflexifol-clinical-data-at-asco-gastrointestin 2024-02-05T22:30:01+11:00 http://pharmadispatch.com/news/radiopharm-updates-on-models-of-pan-cancer-antibody-dunp19 2024-02-05T22:42:01+11:00 http://pharmadispatch.com/news/mark-butler-these-listings-will-have-a-profound-impact-on-people 2024-02-05T23:11:01+11:00 http://pharmadispatch.com/news/psa-uses-its-pre-budget-submission-to-call-for-more-service-base 2024-02-05T23:28:01+11:00 http://pharmadispatch.com/news/what-matters-now-is-avoiding-delusion-and-not-repeating-previous 2024-02-07T14:00:01+11:00 http://pharmadispatch.com/news/industry-calls-for-sustainable-funding-sought-for-clinical-trial 2024-02-07T14:00:01+11:00 http://pharmadispatch.com/news/government-invests-in-development-of-world-first-tissue-engineer 2024-02-07T14:00:01+11:00 http://pharmadispatch.com/news/the-proposed-centralisation-of-power-in-a-single-committee-needs 2024-02-08T14:00:01+11:00 http://pharmadispatch.com/news/private-health-insurers-say-price-gouging-doctors-should-be-name 2024-02-08T02:03:01+11:00 http://pharmadispatch.com/news/report-recommends-mandatory-reporting-of-arrangements-with-no-ev 2024-02-08T14:00:01+11:00 http://pharmadispatch.com/news/us-fda-approves-edwards-evoque-system-for-major-heart-valve-dise 2024-02-08T03:11:01+11:00 http://pharmadispatch.com/news/medibank-offering-members-50-to-put-towards-dental-out-of-pocket 2024-02-08T06:07:01+11:00 http://pharmadispatch.com/news/australian-company-signs-mou-with-indonesian-partner-to-progress 2024-02-08T14:00:01+11:00 http://pharmadispatch.com/news/that-is-why-vaccines-matter-andare-one-of-the-most-critical-publ 2024-02-09T14:00:01+11:00 http://pharmadispatch.com/news/abbvie-announces-the-appointment-of-new-nz-country-head 2024-02-09T03:22:01+11:00 http://pharmadispatch.com/news/tga-extends-approval-for-vertexs-cystic-fibrosis-therapy-ahead-o 2024-02-09T03:35:01+11:00 http://pharmadispatch.com/news/the-week-in-review-podcast-9-february 2024-02-10T00:01:01+11:00 http://pharmadispatch.com/news/focus-on-the-governments-proposals-because-theyre-most-likely-to 2024-02-12T14:00:01+11:00 http://pharmadispatch.com/news/franklin-women-and-organon-partner-to-launch-members-connect-ser 2024-02-12T14:00:01+11:00 http://pharmadispatch.com/news/research-australia-launches-abbvie-backed-mentorship-program 2024-02-12T14:00:01+11:00 http://pharmadispatch.com/news/sandoz-secures-australian-rights-to-two-biosimilar-brands 2024-02-12T14:00:01+11:00 http://pharmadispatch.com/news/options-paper-proposes-limits-on-process-for-the-most-important- 2024-02-13T14:00:01+11:00 http://pharmadispatch.com/news/disappointment-as-csls-leading-heart-candidate-misses-in-clinica 2024-02-13T14:00:01+11:00 http://pharmadispatch.com/news/cyclopharm-announces-the-appointment-of-new-chief-financial-offi 2024-02-13T04:00:01+11:00 http://pharmadispatch.com/news/hundreds-of-people-access-national-pharmacies-store-in-first-wee 2024-02-13T04:09:01+11:00 http://pharmadispatch.com/news/bupa-ventures-to-invest-20m-to-accelerate-healthcare-innovations 2024-02-13T04:19:01+11:00 http://pharmadispatch.com/news/can-we-all-just-agree-that-anything-like-pharmac-would-be-unacce 2024-02-14T14:00:01+11:00 http://pharmadispatch.com/news/medicines-australia-silent-on-key-questions-as-early-enthusiasm- 2024-02-14T14:00:01+11:00 http://pharmadispatch.com/news/with-just-nine-days-to-go-people-need-all-the-available-informat 2024-02-14T16:18:01+11:00 http://pharmadispatch.com/news/csl-reports-strong-first-half-growth-with-immunoglobulins-the-hi 2024-02-14T03:27:01+11:00 http://pharmadispatch.com/news/conflicting-messages-and-compare-and-contrast-these-processes 2024-02-15T14:00:01+11:00 http://pharmadispatch.com/news/australian-company-launches-new-blood-cancer-trial-of-lead-candi 2024-02-15T14:00:01+11:00 http://pharmadispatch.com/news/pcpa-invites-medical-oncologists-and-cancer-nurses-to-participat 2024-02-15T14:00:01+11:00 http://pharmadispatch.com/news/patients-welcome-funding-but-challenge-pharmac-over-eligibility- 2024-02-15T16:21:01+11:00 http://pharmadispatch.com/news/senior-officials-defend-appointment-of-former-tga-head-to-ma-boa 2024-02-16T00:18:01+11:00 http://pharmadispatch.com/news/officials-confirm-the-appointment-of-australias-chief-health-eco 2024-02-16T14:00:01+11:00 http://pharmadispatch.com/news/ongoing-debate-over-the-industrys-response-to-hta-review-options 2024-02-16T14:00:01+11:00 http://pharmadispatch.com/news/gsk-negotiates-deal-with-new-zealands-pharmac-for-four-medicines 2024-02-16T14:00:01+11:00 http://pharmadispatch.com/news/the-week-in-review-podcast-16-february 2024-02-16T22:07:01+11:00 http://pharmadispatch.com/news/the-reference-committee-agreed-the-content-of-the-options-paper- 2024-02-19T14:00:01+11:00 http://pharmadispatch.com/news/medicines-australia-moderates-celebratory-tone-in-new-member-bri 2024-02-19T16:00:01+11:00 http://pharmadispatch.com/news/if-this-is-the-real-view-then-the-onus-is-on-the-association-to- 2024-02-19T16:13:01+11:00 http://pharmadispatch.com/news/not-the-first-time-the-pbac-has-been-given-more-power-to-streaml 2024-02-20T14:00:01+11:00 http://pharmadispatch.com/news/officials-were-planning-joint-negotiations-while-senate-consider 2024-02-20T14:00:01+11:00 http://pharmadispatch.com/news/csl-seqirus-welcomes-extended-approval-for-iron-treatment 2024-02-20T14:00:01+11:00 http://pharmadispatch.com/news/a-remarkable-coincidence-or-an-extraordinary-attempt-to-conceal- 2024-02-20T14:00:01+11:00 http://pharmadispatch.com/news/certa-therapeutics-ft011-granted-us-fda-fast-track-for-systemic- 2024-02-20T04:43:01+11:00 http://pharmadispatch.com/news/ltr-pharma-says-patient-recruitment-commences-for-pivotal-clinic 2024-02-20T00:58:01+11:00 http://pharmadispatch.com/news/the-dispatched-podcast-21-february 2024-02-21T04:25:01+11:00 http://pharmadispatch.com/news/previous-public-statements-about-hta-policies-and-outcomes-are-c 2024-02-21T14:00:01+11:00 http://pharmadispatch.com/news/new-zealand-moves-to-widen-access-to-popular-cold-and-flu-medici 2024-02-21T14:00:01+11:00 http://pharmadispatch.com/news/its-in-the-name-a-stakeholder-with-an-interest-has-a-stake-not-a 2024-02-22T14:00:01+11:00 http://pharmadispatch.com/news/tga-approves-new-indication-for-bi-lilly-alliance-sglt-2-inhibit 2024-02-22T14:00:01+11:00 http://pharmadispatch.com/news/mtpconnect-says-ttra-program-delivering-at-its-halfway-mark 2024-02-22T14:00:01+11:00 http://pharmadispatch.com/news/sanofi-launches-new-accessibility-action-plan-with-a-focus-on-re 2024-02-23T14:00:01+11:00 http://pharmadispatch.com/news/msac-doubles-down-and-defers-outcomes-despite-ministers-criticis 2024-02-23T14:00:01+11:00 http://pharmadispatch.com/news/gsk-topping-the-pharma-cup-leaderboard-with-three-weeks-to-go 2024-02-23T14:00:01+11:00 http://pharmadispatch.com/news/gedeon-richter-welcomes-tga-approval-of-endometriosis-treatment 2024-02-23T14:00:01+11:00 http://pharmadispatch.com/news/the-week-in-review-podcast-23-february 2024-02-23T21:49:01+11:00 http://pharmadispatch.com/news/consultation-is-closed-the-industry-must-now-decide-what-side-of 2024-02-26T14:00:01+11:00 http://pharmadispatch.com/news/before-i-was-diagnosed-i-didnt-know-much-about-shingles-and-the- 2024-02-26T14:00:01+11:00 http://pharmadispatch.com/news/daiichi-sankyo-welcomes-more-senior-executives-to-australia 2024-02-26T14:00:01+11:00 http://pharmadispatch.com/news/a-nz-cancer-doctor-gives-their-view-of-why-reform-of-pharmac-mat 2024-02-27T14:00:01+11:00 http://pharmadispatch.com/news/investors-back-avita-medical-after-it-reported-full-year-results 2024-02-27T00:32:01+11:00 http://pharmadispatch.com/news/novartis-asthma-therapy-dramatically-reduces-the-risk-of-allergi 2024-02-27T14:00:01+11:00 http://pharmadispatch.com/news/new-survey-reveals-the-gap-between-men-and-women-living-with-pai 2024-02-27T14:00:01+11:00 http://pharmadispatch.com/news/health-department-launches-a-rapid-internal-review-of-national-i 2024-02-28T14:00:01+11:00 http://pharmadispatch.com/news/the-backdrop-of-reviews-and-process-clearly-suggests-that-someth 2024-02-28T14:00:01+11:00 http://pharmadispatch.com/news/new-arthritis-australia-report-reveals-the-future-impact-on-the- 2024-02-28T14:00:01+11:00 http://pharmadispatch.com/news/health-department-partners-with-google-cloud-to-consolidate-data 2024-02-28T14:00:01+11:00 http://pharmadispatch.com/news/nyrada-says-preclinical-brain-injury-study-shows-statistically-s 2024-02-28T21:02:01+11:00 http://pharmadispatch.com/news/pharmac-minister-announces-new-parallel-assessment-for-medicines 2024-02-29T14:00:01+11:00 http://pharmadispatch.com/news/neuren-pharmaceuticals-reports-fourth-quarter-royalties-from-day 2024-02-28T22:28:01+11:00 http://pharmadispatch.com/news/novartis-commissioned-report-calls-for-change-in-cvd-management 2024-02-29T14:00:01+11:00 http://pharmadispatch.com/news/ma-backtracks-and-delivers-a-scathing-response-to-hta-review-opt 2024-02-29T14:00:01+11:00 http://pharmadispatch.com/news/agreements-that-started-with-limits-have-become-vehicles-for-gov 2024-03-01T14:00:01+11:00 http://pharmadispatch.com/news/ausbiotech-says-it-cannot-support-new-basis-for-cost-recovery-fe 2024-03-01T14:00:01+11:00 http://pharmadispatch.com/news/todd-stephenson-joins-minister-david-seymour-in-first-visit-to-p 2024-03-01T14:00:01+11:00 http://pharmadispatch.com/news/fundraising-totals-build-with-just-two-weeks-until-this-years-ko 2024-03-01T14:00:01+11:00 http://pharmadispatch.com/news/the-week-in-review-podcast-1-march 2024-03-01T21:57:01+11:00 http://pharmadispatch.com/news/csl-confirms-the-sale-of-historic-parkville-site-after-more-than 2024-03-04T14:00:01+11:00 http://pharmadispatch.com/news/roche-welcomes-registration-of-the-first-subcutaneous-pd-l1-canc 2024-03-04T14:00:01+11:00 http://pharmadispatch.com/news/government-to-launch-new-awareness-campaign-in-response-to-low-6 2024-03-04T14:00:01+11:00 http://pharmadispatch.com/news/expanded-funding-of-spinraza-for-treatment-of-pre-symptomatic-sm 2024-03-04T14:00:01+11:00 http://pharmadispatch.com/news/immunisation-against-respiratory-illnesses-become-the-focus 2024-03-04T14:00:01+11:00 http://pharmadispatch.com/news/significant-change-is-coming-if-these-recent-appointments-are-an 2024-03-04T14:00:01+11:00 http://pharmadispatch.com/news/mark-butler-lauds-the-expanded-pbs-listing-of-astrazeneca-therap 2024-03-04T14:00:01+11:00 http://pharmadispatch.com/news/ama-says-uptake-of-60-day-prescriptions-was-never-going-to-happe 2024-03-05T14:00:01+11:00 http://pharmadispatch.com/news/data-management-company-enlitic-appoints-experienced-executive-t 2024-03-05T00:17:01+11:00 http://pharmadispatch.com/news/research-based-industry-welcomes-decision-not-to-extend-covid-19 2024-03-05T14:00:01+11:00 http://pharmadispatch.com/news/emvision-medical-devices-secures-strategic-investment-from-us-ba 2024-03-05T01:33:01+11:00 http://pharmadispatch.com/news/no-confidentiality-undertakings-yet-but-the-minister-has-given-t 2024-03-05T14:00:01+11:00 http://pharmadispatch.com/news/nsw-government-lauds-the-impact-of-pharmacy-scope-of-practice-tr 2024-03-05T22:09:01+11:00 http://pharmadispatch.com/news/western-australia-acts-quickly-to-fund-access-to-sanofis-rsv-vac 2024-03-06T14:00:01+11:00 http://pharmadispatch.com/news/pre-budget-period-set-to-intensify-as-pharmacy-agreement-moves-o 2024-03-06T14:00:01+11:00 http://pharmadispatch.com/news/rare-cancers-australia-calls-for-rapid-funding-of-paediatric-bra 2024-03-06T14:00:01+11:00 http://pharmadispatch.com/news/three-times-in-fives-years-industry-gave-up-prices-so-why-would- 2024-03-07T14:00:01+11:00 http://pharmadispatch.com/news/clarity-pharmaceuticals-says-sar-bispsma-detects-pc-lesions-in-t 2024-03-06T21:50:01+11:00 http://pharmadispatch.com/news/nyrada-successfully-raises-1755-million-to-support-the-developme 2024-03-06T22:34:01+11:00 http://pharmadispatch.com/news/adalta-announces-positive-results-from-phase-1-extension-study-o 2024-03-07T00:14:01+11:00 http://pharmadispatch.com/news/health-department-rejects-state-and-territory-requests-for-early 2024-03-07T14:00:01+11:00 http://pharmadispatch.com/news/msd-surges-to-the-lead-with-just-over-one-week-until-this-years- 2024-03-07T14:00:01+11:00 http://pharmadispatch.com/news/stakeholders-can-now-see-what-the-industry-really-thinks-about-h 2024-03-08T14:00:01+11:00 http://pharmadispatch.com/news/organons-nirelle-tolstoshev-says-its-a-day-to-demonstrate-intent 2024-03-08T14:00:01+11:00 http://pharmadispatch.com/news/the-week-in-review-podcasr-8-march 2024-03-08T14:00:01+11:00 http://pharmadispatch.com/news/ausbiotech-and-medicines-australia-to-host-annual-women-in-life- 2024-03-08T14:00:01+11:00 http://pharmadispatch.com/news/industry-hits-back-at-president-biden-following-criticism-in-sta 2024-03-11T14:00:01+11:00 http://pharmadispatch.com/news/tga-tightens-interpretation-of-advertising-regulations-to-elimin 2024-03-11T14:00:01+11:00 http://pharmadispatch.com/news/the-process-looked-like-a-teddy-bear-but-a-closer-look-has-revea 2024-03-11T14:00:01+11:00 http://pharmadispatch.com/news/dimerixs-dmx-200-successfully-passes-interim-analysis-in-action3 2024-03-11T22:37:01+11:00 http://pharmadispatch.com/news/msd-maintains-pharma-cup-lead-with-companies-adding-75000-in-fou 2024-03-12T14:00:01+11:00 http://pharmadispatch.com/news/imricor-says-paris-based-cv-institute-grants-ethics-approval-for 2024-03-12T02:34:01+11:00 http://pharmadispatch.com/news/mesoblast-says-us-fda-feedback-indicates-support-for-accelerated 2024-03-12T02:45:01+11:00 http://pharmadispatch.com/news/when-the-minister-delegates-decision-making-they-delegate-decisi 2024-03-13T14:00:01+11:00 http://pharmadispatch.com/news/competition-regulator-launches-a-review-of-chemist-warehouse-sig 2024-03-13T14:00:01+11:00 http://pharmadispatch.com/news/dimerix-raises-20-million-to-continue-and-expand-late-stage-clin 2024-03-12T23:43:01+11:00 http://pharmadispatch.com/news/pharmacies-prepare-to-gather-in-queensland-for-the-annual-app-co 2024-03-13T14:00:01+11:00 http://pharmadispatch.com/news/former-roche-executive-appointed-to-lead-not-for-profit-omico 2024-03-13T14:00:01+11:00 http://pharmadispatch.com/news/the-predictable-sequencing-of-this-process-is-gradually-being-re 2024-03-14T14:00:01+11:00 http://pharmadispatch.com/news/we-want-to-give-back-to-the-charity-that-gave-so-much-to-us-in-o 2024-03-14T14:00:01+11:00 http://pharmadispatch.com/news/new-zealand-to-fund-pharmacists-to-administer-childhood-vaccinat 2024-03-14T14:00:01+11:00 http://pharmadispatch.com/news/pharmacy-guild-secures-an-additional-3bn-in-new-agreement 2024-03-14T21:38:01+11:00 http://pharmadispatch.com/news/merck-expands-fertility-benefit-for-its-employees-in-australia 2024-03-15T14:00:01+11:00 http://pharmadispatch.com/news/week-in-review-podcast-15-march 2024-03-15T05:15:01+11:00 http://pharmadispatch.com/news/psa-says-it-will-continue-to-advocate-for-an-expanded-scope-of-p 2024-03-15T14:00:01+11:00 http://pharmadispatch.com/news/what-do-people-think-the-minister-means-by-finalising-separate-a 2024-03-15T14:00:01+11:00 http://pharmadispatch.com/news/a-misguided-response-that-is-disconnected-from-its-own-history-a 2024-03-18T14:00:01+11:00 http://pharmadispatch.com/news/where-are-the-stewards-to-maintain-and-protect-this-critical-pub 2024-03-18T14:00:01+11:00 http://pharmadispatch.com/news/the-fast-finishing-astrazeneca-secures-pharma-cup-for-2024-kosi- 2024-03-18T14:00:01+11:00 http://pharmadispatch.com/news/stakeholders-force-pharmac-backdown-on-move-to-scrap-childhood-c 2024-03-19T14:00:01+11:00 http://pharmadispatch.com/news/viiv-healthcare-australia-announces-recipients-of-2023-positive- 2024-03-19T14:00:01+11:00 http://pharmadispatch.com/news/im-a-big-believer-that-we-as-public-servants-need-to-engage-hone 2024-03-19T14:00:01+11:00 http://pharmadispatch.com/news/developing-and-proactovely-proposing-credible-alternatives-that- 2024-03-20T14:00:01+11:00 http://pharmadispatch.com/news/australian-study-finds-families-gain-the-most-with-treatment-of- 2024-03-20T14:00:01+11:00 http://pharmadispatch.com/news/astrazeneca-roundtable-to-highlight-push-for-australian-interim- 2024-03-20T14:00:01+11:00 http://pharmadispatch.com/news/giulia-jones-ceo-hair-dye-for-the-19-million-australian-women-li 2024-03-20T14:00:01+11:00 http://pharmadispatch.com/news/minister-to-launch-first-major-program-targeting-early-diagnosis 2024-03-20T14:00:01+11:00 http://pharmadispatch.com/news/focus-on-making-high-quality-intellectual-cases-in-support-of-sp 2024-03-22T14:00:01+11:00 http://pharmadispatch.com/news/australian-patients-now-one-step-closer-to-accessing-csls-one-ti 2024-03-21T14:00:01+11:00 http://pharmadispatch.com/news/applications-open-for-modernas-2024-australia-fellowship-program 2024-03-21T14:00:01+11:00 http://pharmadispatch.com/news/gbma-announces-changes-to-its-board-at-a-pivotal-time-in-austral 2024-03-21T14:00:01+11:00 http://pharmadispatch.com/news/rhythm-biosciences-establishes-internationally-renowned-clinical 2024-03-21T01:51:01+11:00 http://pharmadispatch.com/news/ltr-pharma-says-first-patient-first-dose-in-the-spontan-pivotal- 2024-03-21T02:09:01+11:00 http://pharmadispatch.com/news/these-must-be-the-two-worst-appointments-imaginable-for-patients 2024-03-21T03:46:01+11:00 http://pharmadispatch.com/news/look-at-these-appointments-and-ideas-like-the-pieces-of-a-puzzle 2024-03-21T14:00:01+11:00 http://pharmadispatch.com/news/chemist-warehouse-reveals-rapid-growth-in-sigma-full-year-result 2024-03-21T22:39:01+11:00 http://pharmadispatch.com/news/new-mind-the-treatment-gap-campaign-to-focus-attention-on-drug-r 2024-03-22T14:00:01+11:00 http://pharmadispatch.com/news/the-week-in-review-podcast-22-march 2024-03-22T02:15:01+11:00 http://pharmadispatch.com/news/once-again-history-is-the-guide-in-that-these-appointments-are-r 2024-03-25T14:00:01+11:00 http://pharmadispatch.com/news/if-the-governemnt-expands-their-power-they-need-to-be-made-more- 2024-03-25T14:00:01+11:00 http://pharmadispatch.com/news/new-zealand-moves-closer-to-funding-cgm-as-australia-waits-for-t 2024-03-25T14:00:01+11:00 http://pharmadispatch.com/news/more-states-announces-rsv-programs-as-families-call-for-national 2024-03-26T14:00:01+11:00 http://pharmadispatch.com/news/new-study-reveals-impact-of-restrictions-imposed-on-pbs-listed-o 2024-03-26T14:00:01+11:00 http://pharmadispatch.com/news/painaustralia-ceo-goes-red-for-the-19-million-women-living-with- 2024-03-26T14:00:01+11:00 http://pharmadispatch.com/news/pfizer-releases-2023-impact-report-revealing-progress-on-environ 2024-03-26T14:00:01+11:00 http://pharmadispatch.com/news/orthocell-successfully-completes-all-nerve-repair-surgeries-in-r 2024-03-26T03:13:01+11:00 http://pharmadispatch.com/news/cochlear-announces-the-resignation-of-non-executive-director-yas 2024-03-26T03:21:01+11:00 http://pharmadispatch.com/news/reform-bill-redefines-political-donation-and-could-exclude-the-i 2024-03-27T14:00:01+11:00 http://pharmadispatch.com/news/clarity-pharmaceuticals-launches-121-million-fully-underwritten- 2024-03-26T22:38:01+11:00 http://pharmadispatch.com/news/nz-government-delivers-funding-boost-for-patients-travelling-to- 2024-03-27T14:00:01+11:00 http://pharmadispatch.com/news/gilead-announces-recipients-of-inaugural-260k-community-grants-p 2024-03-28T14:00:01+11:00 http://pharmadispatch.com/news/cancer-groups-call-for-a-new-approach-to-reviewing-and-funding-c 2024-03-28T14:00:01+11:00 http://pharmadispatch.com/news/auditor-general-extends-time-to-contribute-to-pbs-performance-au 2024-03-28T14:00:01+11:00 http://pharmadispatch.com/news/bi-lilly-alliance-mark-kidney-disease-pbs-listing-for-sglt-2-inh 2024-04-02T14:00:01+11:00 http://pharmadispatch.com/news/patients-are-still-dying-waiting-for-access-almost-one-year-on-f 2024-04-02T14:00:01+11:00 http://pharmadispatch.com/news/pharmac-proposes-funding-cgm-as-companies-wait-for-australian-te 2024-04-02T14:00:01+11:00 http://pharmadispatch.com/news/novartis-welcomes-the-listing-of-first-in-class-cholesterol-lowe 2024-04-02T16:22:01+11:00 http://pharmadispatch.com/news/if-they-choose-to-ignore-the-minister-what-chance-does-anyone-el 2024-04-03T14:00:01+11:00 http://pharmadispatch.com/news/fees-to-rise-as-new-impact-statement-confirms-review-and-updated 2024-04-03T14:00:01+11:00 http://pharmadispatch.com/news/at-risk-australians-now-have-access-to-a-funded-cell-based-flu-v 2024-04-03T14:00:01+11:00 http://pharmadispatch.com/news/research-grant-to-advance-locally-developed-potential-ovarian-ca 2024-04-03T14:00:01+11:00 http://pharmadispatch.com/news/cartherics-enters-new-collaborative-research-agreement-with-tica 2024-04-03T20:47:01+11:00 http://pharmadispatch.com/news/firebrick-pharma-says-nasodine-phase-2-covid-19-trial-results-pu 2024-04-03T20:52:01+11:00 http://pharmadispatch.com/news/investors-welcome-mesoblast-update-and-pathway-for-resubmission- 2024-04-03T20:54:01+11:00 http://pharmadispatch.com/news/ausbiotech-invites-submissions-on-sessions-and-speakers-for-nati 2024-04-03T21:33:01+11:00 http://pharmadispatch.com/news/it-is-not-an-act-of-the-person-who-delegated-the-power-to-the-de 2024-04-04T14:00:01+11:00 http://pharmadispatch.com/news/pbac-to-consider-some-much-anticipated-therapies-at-its-july-mee 2024-04-04T14:00:01+11:00 http://pharmadispatch.com/news/medicines-australia-launches-review-of-its-code-of-conduct 2024-04-04T14:00:01+11:00 http://pharmadispatch.com/news/sanofi-welcomes-new-lung-cancer-listin-for-immune-checkpoint-inh 2024-04-04T14:00:01+11:00 http://pharmadispatch.com/news/astellas-pharma-welcomes-approval-of-first-of-its-kind-non-hormo 2024-04-05T14:00:01+11:00 http://pharmadispatch.com/news/nz-health-minister-launches-national-flu-vaccine-campaign 2024-04-04T22:20:01+11:00 http://pharmadispatch.com/news/the-week-in-review-podcast-5-april 2024-04-05T14:00:01+11:00 http://pharmadispatch.com/news/biotron-provides-update-on-preliminary-analyses-of-data-from-bit 2024-04-05T21:58:01+11:00 http://pharmadispatch.com/news/submission-highlights-the-success-of-first-population-level-vacc 2024-04-08T13:00:01+10:00 http://pharmadispatch.com/news/why-not-use-the-existing-rhta-process-thats-consistent-with-exis 2024-04-08T13:00:01+10:00 http://pharmadispatch.com/news/regulator-seizes-unapproved-compounded-semaglutide-in-sydney-rai 2024-04-08T13:00:01+10:00 http://pharmadispatch.com/news/australian-company-starpharma-partners-with-uk-investment-firm-t 2024-04-08T20:48:01+10:00 http://pharmadispatch.com/news/chimeric-secures-us-patent-for-its-chm-0201-cell-therapy-platfor 2024-04-08T21:26:01+10:00 http://pharmadispatch.com/news/diabetes-drug-improves-cardiovascular-outcomes-across-a-range-of 2024-04-08T22:30:01+10:00 http://pharmadispatch.com/news/mark-butler-says-179-listings-with-additional-funding-in-22-mont 2024-04-09T13:00:01+10:00 http://pharmadispatch.com/news/of-all-the-processes-currently-underway-this-is-the-one-most-lik 2024-04-10T13:00:01+10:00 http://pharmadispatch.com/news/budeven-if-the-budget-does-not-include-specific-measures-it-does 2024-04-11T13:00:01+10:00 http://pharmadispatch.com/news/patients-pushing-for-positive-outcome-on-msds-therapy-for-rare-d 2024-04-10T13:00:01+10:00 http://pharmadispatch.com/news/medical-software-companies-deliver-a-scathing-assessment-of-pbs- 2024-04-10T13:00:01+10:00 http://pharmadispatch.com/news/association-dared-to-say-what-everyone-else-was-thinking-and-reg 2024-04-11T13:00:01+10:00 http://pharmadispatch.com/news/monash-partners-comprehensive-cancer-consortium-awards-precision 2024-04-10T22:02:01+10:00 http://pharmadispatch.com/news/nz-migraine-advocates-say-not-enough-effective-safe-treatments-a 2024-04-11T13:00:01+10:00 http://pharmadispatch.com/news/european-parliament-backs-trade-off-change-in-clinical-data-prot 2024-04-12T13:00:01+10:00 http://pharmadispatch.com/news/three-quarters-at-higher-risk-of-serious-illness-from-covid-19-d 2024-04-12T13:00:01+10:00 http://pharmadispatch.com/news/companies-were-given-just-three-months-to-implement-major-system 2024-04-12T13:00:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-12-april 2024-04-12T21:22:01+10:00 http://pharmadispatch.com/news/who-more-than-these-children-deserve-direct-action-from-their-he 2024-04-15T13:00:01+10:00 http://pharmadispatch.com/news/david-seymour-confirms-that-pseudoephedrine-will-ne-back-on-phar 2024-04-15T13:00:01+10:00 http://pharmadispatch.com/news/gsk-agrees-bundle-with-pharmac-that-funds-and-expanded-access-to 2024-04-15T13:00:01+10:00 http://pharmadispatch.com/news/ex-ausbiotech-appointed-to-lead-peak-body-for-manufacturing-tech 2024-04-16T13:00:01+10:00 http://pharmadispatch.com/news/plan-recommends-greater-transparency-and-accountability-of-healt 2024-04-16T13:00:01+10:00 http://pharmadispatch.com/news/seaport-therapeutics-receives-100-million-in-funding-to-maximise 2024-04-15T22:39:01+10:00 http://pharmadispatch.com/news/hta-review-extended-by-three-weeks-following-reference-committee 2024-04-16T13:00:01+10:00 http://pharmadispatch.com/news/gilead-celebrates-25-years-in-australia-and-nz-with-official-off 2024-04-16T13:00:01+10:00 http://pharmadispatch.com/news/retail-leaders-surprise-at-the-size-of-revenue-revealed-by-chemi 2024-04-17T13:00:01+10:00 http://pharmadispatch.com/news/longstanding-health-sector-leader-and-advocate-steps-down-after- 2024-04-17T13:00:01+10:00 http://pharmadispatch.com/news/as-we-celebrate-our-60th-anniversary-in-australia-i-am-extremely 2024-04-17T13:00:01+10:00 http://pharmadispatch.com/news/if-coercion-and-retribution-are-bad-for-supermarket-customers-th 2024-04-18T13:00:01+10:00 http://pharmadispatch.com/news/abbvie-announces-the-appointment-of-new-australia-nz-human-resou 2024-04-18T13:00:01+10:00 http://pharmadispatch.com/news/under-karens-leadership-our-local-business-has-thrived-both-comm 2024-04-18T13:00:01+10:00 http://pharmadispatch.com/news/the-hta-review-reference-committee-should-ask-themselves-one-que 2024-04-18T21:08:01+10:00 http://pharmadispatch.com/news/new-novartis-backed-report-identifies-nuclear-medicine-opportuni 2024-04-19T13:00:01+10:00 http://pharmadispatch.com/news/scope-of-practice-review-recommends-formation-of-new-committee 2024-04-19T13:00:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-19-april 2024-04-19T22:04:01+10:00 http://pharmadispatch.com/news/dont-be-alarmed-by-a-flat-or-declining-forecast-because-it-will- 2024-04-22T13:00:01+10:00 http://pharmadispatch.com/news/pharmacy-groups-welcome-expansion-of-flu-vaccine-program 2024-04-22T13:00:01+10:00 http://pharmadispatch.com/news/community-organisations-receive-grants-via-global-gileads-all4li 2024-04-22T13:00:01+10:00 http://pharmadispatch.com/news/should-principles-such-as-equity-and-opportunity-cost-be-applied 2024-04-23T13:00:01+10:00 http://pharmadispatch.com/news/rare-cancers-australia-welcomes-new-appointments-to-its-board 2024-04-23T13:00:01+10:00 http://pharmadispatch.com/news/bms-and-australian-venture-capital-firm-back-immunotherapy-compa 2024-04-23T13:00:01+10:00 http://pharmadispatch.com/news/mark-butler-announces-nhmrc-funding-for-six-telehealth-research- 2024-04-22T22:27:01+10:00 http://pharmadispatch.com/news/tour-de-cure-backs-further-development-of-noxopharms-preclinical 2024-04-22T23:38:01+10:00 http://pharmadispatch.com/news/nz-patients-campaigning-against-pharmacs-decision-to-force-a-swi 2024-04-23T13:00:01+10:00 http://pharmadispatch.com/news/ausbiotech-appoints-experienced-sanofi-leader-as-its-new-chief-e 2024-04-23T23:55:01+10:00 http://pharmadispatch.com/news/but-for-medicines-we-spend-a-lot-less-than-other-countries-and-s 2024-04-24T13:00:01+10:00 http://pharmadispatch.com/news/novartis-nominates-ex-bms-chief-executive-as-its-new-chair 2024-04-24T15:04:01+10:00 http://pharmadispatch.com/news/tour-de-cure-backs-further-development-of-noxopharms-preclinical 2024-04-24T15:22:01+10:00 http://pharmadispatch.com/news/lets-make-decisions-based-on-credible-information-and-not-guessw 2024-04-24T20:37:01+10:00 http://pharmadispatch.com/news/new-research-shows-adult-vaccination-programs-deliver-major-retu 2024-04-26T13:00:01+10:00 http://pharmadispatch.com/news/proproductivity-commission-research-provides-irrefutable-evidenc 2024-04-26T13:00:01+10:00 http://pharmadispatch.com/news/nz-government-appoints-former-deputy-pm-new-chair-of-pharmac 2024-04-29T13:00:01+10:00 http://pharmadispatch.com/news/the-listing-will-benefit-thousands-of-australian-women-says-mark 2024-04-29T13:00:01+10:00 http://pharmadispatch.com/news/an-important-first-step-to-achieving-reimbursed-access-for-eligi 2024-04-29T02:11:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-26-april 2024-04-29T02:11:01+10:00 http://pharmadispatch.com/news/summits-day-one-provided-critical-lessons-for-both-sides-of-the- 2024-04-30T13:00:01+10:00 http://pharmadispatch.com/news/important-for-me-to-share-the-full-picture-as-we-must-never-allo 2024-04-30T13:00:01+10:00 http://pharmadispatch.com/news/nz-government-commits-new-funding-to-address-pharmacs-fiscal-cli 2024-04-30T02:19:01+10:00 http://pharmadispatch.com/news/the-term-independent-is-used-to-absolve-decision-makers-of-respo 2024-05-01T13:00:01+10:00 http://pharmadispatch.com/news/the-journey-for-people-living-with-severe-psoriasis-can-be-long- 2024-05-01T13:00:01+10:00 http://pharmadispatch.com/news/pfizer-welcomes-pbs-listing-of-therapy-for-rare-heart-condition 2024-05-01T13:00:01+10:00 http://pharmadispatch.com/news/first-in-class-targeted-therapy-for-obstructive-hypertrophic-car 2024-05-01T13:00:01+10:00 http://pharmadispatch.com/news/another-reform-process-fails-how-many-times-does-this-need-to-ha 2024-05-02T13:00:01+10:00 http://pharmadispatch.com/news/new-coalition-established-to-advocate-for-action-on-radiation-th 2024-05-02T13:00:01+10:00 http://pharmadispatch.com/news/illumina-partners-with-the-garvan-on-major-new-genome-project 2024-05-02T13:00:01+10:00 http://pharmadispatch.com/news/new-data-shows-significant-increase-in-the-number-of-pharmacies- 2024-05-03T13:00:01+10:00 http://pharmadispatch.com/news/csl-seqirus-secures-local-rights-to-new-adrenaline-nasal-spray 2024-05-03T13:00:01+10:00 http://pharmadispatch.com/news/industry-applauds-funding-commitment-for-national-one-stop-shop- 2024-05-03T13:00:01+10:00 http://pharmadispatch.com/news/please-do-not-redefine-government-supported-access-as-including- 2024-05-03T13:00:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-3-may 2024-05-03T22:16:01+10:00 http://pharmadispatch.com/news/the-truth-is-more-that-they-are-the-heroes-of-every-walk-of-life 2024-05-06T13:00:01+10:00 http://pharmadispatch.com/news/hta-reviews-final-report-now-sits-with-health-minister-mark-butl 2024-05-06T13:00:01+10:00 http://pharmadispatch.com/news/the-secrecy-of-the-process-was-wrong-but-the-report-is-now-the-m 2024-05-06T13:00:01+10:00 http://pharmadispatch.com/news/no-timeline-from-the-minister-on-hta-review-report-and-response 2024-05-07T13:00:01+10:00 http://pharmadispatch.com/news/the-pbac-chair-appointment-took-effect-when-it-did-because-it-ha 2024-05-07T13:00:01+10:00 http://pharmadispatch.com/news/pharmacy-groups-call-for-extension-of-the-new-commonwealth-prac- 2024-05-07T13:00:01+10:00 http://pharmadispatch.com/news/amgen-and-arrotex-announce-new-osteoporosis-focused-partnership 2024-05-07T13:00:01+10:00 http://pharmadispatch.com/news/tga-approves-ucbs-pbac-recommended-interleukin-inhibitor 2024-05-08T13:00:01+10:00 http://pharmadispatch.com/news/home-affairs-minister-reveals-the-facts-on-the-independence-of-a 2024-05-08T13:00:01+10:00 http://pharmadispatch.com/news/tga-seeks-nominations-for-statutory-advisory-committees 2024-05-08T01:01:01+10:00 http://pharmadispatch.com/news/momentum-clinical-research-recruiting-for-australian-based-clini 2024-05-08T01:26:01+10:00 http://pharmadispatch.com/news/ausbiotech-policy-leader-appointed-to-lead-biomelbourne-network 2024-05-08T13:00:01+10:00 http://pharmadispatch.com/news/new-research-paper-highlight-potential-but-current-failings-of-d 2024-05-09T04:33:01+10:00 http://pharmadispatch.com/news/launch-of-new-queensland-based-research-and-manufacturing-hub-ta 2024-05-08T21:13:01+10:00 http://pharmadispatch.com/news/island-announces-reallocation-of-us-grant-funding-to-support-new 2024-05-08T21:15:01+10:00 http://pharmadispatch.com/news/bristol-myers-squibb-announces-new-country-medical-director-for- 2024-05-08T21:22:01+10:00 http://pharmadispatch.com/news/parliamentary-inquiry-recommends-reforming-access-arrangements-f 2024-05-08T21:38:01+10:00 http://pharmadispatch.com/news/novartis-monash-university-and-monash-health-partner-vision-for- 2024-05-09T13:00:01+10:00 http://pharmadispatch.com/news/liz-selby-named-sanofis-new-acting-country-lead-and-head-of-phar 2024-05-10T13:00:01+10:00 http://pharmadispatch.com/news/neuren-repors-growing-us-sales-of-australian-developed-product-f 2024-05-10T13:11:01+10:00 http://pharmadispatch.com/news/mark-butler-highlights-listing-of-medicines-for-serious-heart-co 2024-05-10T13:00:01+10:00 http://pharmadispatch.com/news/mark-butler-highlights-listing-of-medicines-for-serious-heart-co 2024-05-10T13:31:01+10:00 http://pharmadispatch.com/news/the-industrys-own-experience-reveals-the-importance-of-caution-i 2024-05-13T13:00:01+10:00 http://pharmadispatch.com/news/us-lawmakers-moving-to-ban-industry-partnerships-with-some-major 2024-05-13T13:00:01+10:00 http://pharmadispatch.com/news/budget-week-preview-podcast-12-may 2024-05-13T02:05:01+10:00 http://pharmadispatch.com/news/pre-budget-announcements-keep-coming-for-health-minister-mark-bu 2024-05-14T13:00:01+10:00 http://pharmadispatch.com/news/genesiscare-appoints-experienced-healthcare-executive-to-chair-i 2024-05-14T13:00:01+10:00 http://pharmadispatch.com/news/australian-company-melbourne-based-cell-therapies-as-preferred-m 2024-05-14T13:00:01+10:00 http://pharmadispatch.com/news/some-of-the-signs-might-be-worrying-but-not-for-the-obvious-reas 2024-05-14T13:00:01+10:00 http://pharmadispatch.com/news/race-shares-the-resulsts-of-preclinical-studies-combining-bisant 2024-05-14T22:00:01+10:00 http://pharmadispatch.com/news/tga-seeks-views-on-proposed-medical-device-reform-changes 2024-05-14T23:36:01+10:00 http://pharmadispatch.com/news/patients-secure-cost-of-living-win-with-all-indications-there-is 2024-05-15T05:25:01+10:00 http://pharmadispatch.com/news/the-budget-should-leave-people-in-no-doubt-that-more-announcemen 2024-05-15T13:00:01+10:00 http://pharmadispatch.com/news/stakeholder-response-to-the-albanese-governments-2024-25-budget 2024-05-15T13:00:01+10:00 http://pharmadispatch.com/news/budget-maintains-single-non-financial-performance-indicator-for- 2024-05-15T13:00:01+10:00 http://pharmadispatch.com/news/the-2024-25-budget-review 2024-05-15T13:41:01+10:00 http://pharmadispatch.com/news/generic-and-biosimilar-sector-welcomes-the-governments-cost-of-l 2024-05-16T13:00:01+10:00 http://pharmadispatch.com/news/budget-provides-minimal-support-for-projects-to-build-aps-capabi 2024-05-16T13:00:01+10:00 http://pharmadispatch.com/news/nz-prime-minister-says-we-are-recognising-that-we-have-a-problem 2024-05-16T15:14:01+10:00 http://pharmadispatch.com/news/baxter-launches-the-mission-and-logo-of-new-kidney-care-company 2024-05-17T05:45:01+10:00 http://pharmadispatch.com/news/health-department-makes-a-major-change-inside-critical-divison 2024-05-17T13:00:01+10:00 http://pharmadispatch.com/news/mark-butler-establishes-place-in-history-by-ruling-out-new-pbs-s 2024-05-16T13:00:01+10:00 http://pharmadispatch.com/news/astrazeneca-welcomes-action-on-co-pays-but-calls-for-more-on-acc 2024-05-20T13:00:01+10:00 http://pharmadispatch.com/news/astrazeneca-welcomes-action-on-co-pays-but-calls-for-more-on-acc 2024-05-20T13:00:01+10:00 http://pharmadispatch.com/news/can-we-just-have-an-honest-conversation-about-budget-and-reform- 2024-05-20T15:11:01+10:00 http://pharmadispatch.com/news/just-to-be-clear-the-comment-was-completely-tongue-in-cheek 2024-05-20T16:00:01+10:00 http://pharmadispatch.com/news/rare-cancers-australia-welcomes-recommendations-of-senate-inquir 2024-05-21T15:00:01+10:00 http://pharmadispatch.com/news/naccho-announces-recipients-of-sanofi-supported-pharmacy-scholar 2024-05-21T15:10:01+10:00 http://pharmadispatch.com/news/emerging-australian-biotech-appoints-former-health-minister-to-i 2024-05-21T15:18:01+10:00 http://pharmadispatch.com/news/blood-cancer-taskforce-unveils-new-optimal-care-pathways-for-blo 2024-05-22T14:27:01+10:00 http://pharmadispatch.com/news/australian-clinical-trials-celebrated-on-international-clinical- 2024-05-22T14:34:01+10:00 http://pharmadispatch.com/news/astrazeneca-announces-ambition-to-launch-20-new-drugs-and-almost 2024-05-22T14:46:01+10:00 http://pharmadispatch.com/news/mark-butler-moves-to-ban-unapproved-compounded-weight-loss-medic 2024-05-23T13:00:01+10:00 http://pharmadispatch.com/news/we-have-an-ambitious-reform-agenda-and-are-preparing-for-every-s 2024-05-23T02:17:01+10:00 http://pharmadispatch.com/news/australian-cell-therapy-company-launches-mid-stage-clinical-tria 2024-05-23T15:04:01+10:00 http://pharmadispatch.com/news/there-will-be-increasingly-divergent-outcomes-until-we-stop-this 2024-05-24T13:03:01+10:00 http://pharmadispatch.com/news/an-attack-on-any-element-of-that-supply-chain-is-an-attack-on-al 2024-05-24T13:00:01+10:00 http://pharmadispatch.com/news/mtpconnect-says-australias-clinical-trials-sector-more-valuable 2024-05-24T13:00:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-24-may 2024-05-24T22:29:01+10:00 http://pharmadispatch.com/news/organon-promotes-australia-and-nz-founders-to-asia-pacific-roles 2024-05-27T13:00:01+10:00 http://pharmadispatch.com/news/stem-cell-medicine-advancements-to-be-showcased-at-renews-scient 2024-05-26T20:26:01+10:00 http://pharmadispatch.com/news/racgp-urges-rsv-immunisation-rollout-in-victoria-as-reported-cas 2024-05-26T20:32:01+10:00 http://pharmadispatch.com/news/adherium-will-provide-its-hailie-smartinhaler-for-an-astrazeneca 2024-05-26T20:47:01+10:00 http://pharmadispatch.com/news/trailblazers-talks-with-medicines-australia-ceo-liz-de-somer 2024-05-26T23:07:01+10:00 http://pharmadispatch.com/news/baxter-launches-second-reconciliation-action-plan-to-mark-nation 2024-05-26T23:21:01+10:00 http://pharmadispatch.com/news/when-youre-looking-at-the-choices-you-have-to-make-what-choice-d 2024-05-27T12:00:01+10:00 http://pharmadispatch.com/news/dimerix-announces-middle-east-license-agreement-for-dmx-200 2024-05-27T19:14:01+10:00 http://pharmadispatch.com/news/you-can-almost-say-theres-reform-with-a-small-r-and-theres-refor 2024-05-28T13:00:01+10:00 http://pharmadispatch.com/news/biosimilar-sector-leaders-call-for-comprehensive-reform-to-promo 2024-05-28T13:00:01+10:00 http://pharmadispatch.com/news/neuren-says-trial-shows-significant-improvements-in-pitt-hopkins 2024-05-27T23:59:01+10:00 http://pharmadispatch.com/news/is-the-leadership-driving-reform-and-is-the-industry-ready-for-a 2024-05-29T13:00:01+10:00 http://pharmadispatch.com/news/positive-late-stage-trial-result-for-az-daiichi-sankyo-antibody- 2024-05-29T13:00:01+10:00 http://pharmadispatch.com/news/diabetes-medicine-found-to-reduce-risk-of-kidney-disease-and-dea 2024-05-29T03:25:01+10:00 http://pharmadispatch.com/news/stakeholders-given-two-weeks-to-respond-to-draft-immunisation-st 2024-05-29T14:37:01+10:00 http://pharmadispatch.com/news/australian-company-noxopharm-joins-global-alliance-for-mrna-medi 2024-05-29T19:30:01+10:00 http://pharmadispatch.com/news/one-year-on-and-people-are-still-dying-waiting-for-funded-access 2024-05-30T13:00:01+10:00 http://pharmadispatch.com/news/once-again-how-many-times-will-this-happen-before-someone-takes- 2024-05-30T13:00:01+10:00 http://pharmadispatch.com/news/study-reveals-decline-in-long-term-prescription-opioid-use-after 2024-05-30T13:00:01+10:00 http://pharmadispatch.com/news/percheron-therapeutics-completes-recruitment-in-phase-2b-study-o 2024-05-30T00:09:01+10:00 http://pharmadispatch.com/news/no-responses-on-two-week-consultation-process-as-opposition-call 2024-05-30T03:06:01+10:00 http://pharmadispatch.com/news/the-94-words-that-created-a-national-institution-and-helped-buil 2024-05-31T11:00:01+10:00 http://pharmadispatch.com/news/we-regret-that-it-hasnt-been-possible-in-this-budget 2024-05-31T11:00:01+10:00 http://pharmadispatch.com/news/the-government-developed-this-critical-public-health-strategy-by 2024-05-31T11:00:01+10:00 http://pharmadispatch.com/news/the-week-in-review-31-may 2024-05-31T22:44:01+10:00 http://pharmadispatch.com/news/csl-seqirus-announces-us-government-award-in-response-to-avian-influenza 2024-06-02T20:21:01+10:00 http://pharmadispatch.com/news/states-immunising-infants-against-rsv-reporting-lower-hospitalisations 2024-06-02T20:29:01+10:00 http://pharmadispatch.com/news/medicines-new-zealand-says-budget-delivers-broken-hearts-and-a-third-world-position 2024-06-03T13:00:01+10:00 http://pharmadispatch.com/news/patients-secure-an-additional-two-weeks-but-still-question-the-process 2024-06-02T21:38:01+10:00 http://pharmadispatch.com/news/vertex-welcomes-wider-pbs-listing-for-cystic-fibrosis-therapy-kalydeco 2024-06-02T22:04:01+10:00 http://pharmadispatch.com/news/fda-approves-avita-medicals-recell-go-system 2024-06-03T20:07:01+10:00 http://pharmadispatch.com/news/immutep-announces-major-capital-raise-and-late-stage-collaboration-with-msd 2024-06-03T20:16:01+10:00 http://pharmadispatch.com/news/island-pharmaceuticals-says-new-data-leads-to-isla-101-phase-2-study-changes 2024-06-03T21:10:01+10:00 http://pharmadispatch.com/news/albanese-government-and-pharmacy-guild-sign-new-five-year-agreement 2024-06-03T21:20:01+10:00 http://pharmadispatch.com/news/not-the-end-but-the-first-act-in-a-sequencethat-will-have-a-broader-impact 2024-06-03T21:36:01+10:00 http://pharmadispatch.com/news/would-have-been-so-much-easier-if-this-had-been-done-12-months-ago 2024-06-04T13:00:01+10:00 http://pharmadispatch.com/news/recognition-for-nz-advocate-as-campaign-demands-cancer-medicines-funding 2024-06-04T13:00:01+10:00 http://pharmadispatch.com/news/new-zealands-government-scrambles-to-manage-patient-anger 2024-06-05T13:00:01+10:00 http://pharmadispatch.com/news/brandon-capital-launches-sixth-life-sciences-investment-fund-with-strong-investor-support 2024-06-05T13:00:01+10:00 http://pharmadispatch.com/news/this-is-exactly-why-we-all-need-to-be-looking-to-nz-and-learning 2024-06-05T13:00:01+10:00 http://pharmadispatch.com/news/new-australian-product-partnership-between-sandoz-and-mayne-pharma 2024-06-05T04:21:01+10:00 http://pharmadispatch.com/news/genomic-profiling-prospect-achieves-a-significant-patient-milestone 2024-06-06T13:00:01+10:00 http://pharmadispatch.com/news/chimeric-announces-progress-in-phase-1b-blood-cancer-cell-therapy-trial 2024-06-05T19:54:01+10:00 http://pharmadispatch.com/news/new-national-strategy-demotes-international-and-region-as-a-priority 2024-06-06T13:00:01+10:00 http://pharmadispatch.com/news/cyclopharms-technegas-receives-pass-through-status-from-us-agency 2024-06-05T23:16:01+10:00 http://pharmadispatch.com/news/senior-health-officials-defend-vaccine-funding-process-in-response-to-state-action 2024-06-06T13:00:01+10:00 http://pharmadispatch.com/news/secretary-says-its-not-unusual-for-a-deputy-secretary-to-accept-a-demotion 2024-06-06T02:45:01+10:00 http://pharmadispatch.com/news/officials-confirm-the-sluggish-uptake-of-higher-dispensed-quantities 2024-06-06T20:32:01+10:00 http://pharmadispatch.com/news/hta-review-report-was-professionally-edited-before-it-was-presented-to-mark-butler 2024-06-07T01:33:01+10:00 http://pharmadispatch.com/news/jj-appoints-new-anz-managing-director-as-part-of-global-talent-development-plan 2024-06-07T02:09:01+10:00 http://pharmadispatch.com/news/icon-group-and-5d-clinics-enter-a-joint-venture-to-expand-access-to-cancer-cyberknife 2024-06-07T13:00:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-7-june 2024-06-07T23:20:01+10:00 http://pharmadispatch.com/news/a-potential-healthcare-revolution-growing-outside-the-institutional-funding-framework 2024-06-11T13:00:01+10:00 http://pharmadispatch.com/news/we-want-to-make-a-fundamental-shift-in-the-health-system-for-people-living-with-cancer 2024-06-10T20:59:01+10:00 http://pharmadispatch.com/news/former-tga-head-recognised-in-the-2024-kings-birthday-honours 2024-06-11T13:00:01+10:00 http://pharmadispatch.com/news/leadership-transition-coming-for-organon-australia-and-nz 2024-06-11T04:07:01+10:00 http://pharmadispatch.com/news/moderna-announces-positive-phase-3-data-for-combination-vaccine-against-influenza-and-covid-19 2024-06-11T20:42:01+10:00 http://pharmadispatch.com/news/when-it-comes-to-health-technology-assessment-i-agree-with-mark-butler 2024-06-12T13:00:01+10:00 http://pharmadispatch.com/news/novo-nordisk-makes-senior-public-affairs-and-communications-appointments 2024-06-12T13:00:01+10:00 http://pharmadispatch.com/news/cartherics-secures-an-australian-patent-for-its-cancer-cell-therapy 2024-06-12T20:01:01+10:00 http://pharmadispatch.com/news/opthea-taps-investors-to-raise-almost-230-million-to-fund-late-stage-trials 2024-06-12T20:33:01+10:00 http://pharmadispatch.com/news/department-organon-managing-director-moving-to-astellas-australia 2024-06-13T02:47:01+10:00 http://pharmadispatch.com/news/competition-regulator-outlines-preliminary-competition-concerns-on-cw-sigma-merger 2024-06-13T22:35:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-13-june 2024-06-14T03:08:01+10:00 http://pharmadispatch.com/news/research-australia-challenges-draft-immunisation-strategy-over-major-omissions 2024-06-14T13:00:01+10:00 http://pharmadispatch.com/news/tga-extends-the-use-of-bayer-contraceptive-to-eight-years 2024-06-16T19:52:01+10:00 http://pharmadispatch.com/news/new-report-reveals-the-economic-contribution-of-clinical-trials 2024-06-16T20:10:01+10:00 http://pharmadispatch.com/news/it-might-sounds-like-a-lot-but-are-we-these-office-holders-paid-enough 2024-06-17T13:00:01+10:00 http://pharmadispatch.com/news/lundbeck-scores-again-and-achieves-certification-as-a-great-place-to-work 2024-06-17T15:01:01+10:00 http://pharmadispatch.com/news/access-the-focus-as-uk-based-industry-welcomes-pre-election-manifestos 2024-06-18T00:07:01+10:00 http://pharmadispatch.com/news/the-pharmacy-guild-has-negotiated-an-incredible-agreement 2024-06-18T04:26:01+10:00 http://pharmadispatch.com/news/the-report-likely-to-deliver-enduring-change-will-be-tabled-in-october 2024-06-18T14:49:01+10:00 http://pharmadispatch.com/news/the-pharmacy-guild-is-unique-but-the-past-year-provides-valuable-lessons-for-all-wanting-change 2024-06-19T13:00:01+10:00 http://pharmadispatch.com/news/families-welcome-nsw-budget-investment-to-help-children-with-juvenile-arthritis 2024-06-19T13:00:01+10:00 http://pharmadispatch.com/news/mark-butler-launches-new-australian-company-targeting-hard-to-treat-cancers 2024-06-19T01:17:01+10:00 http://pharmadispatch.com/news/patients-in-new-zealand-welcome-wider-access-to-breast-cancer-therapies 2024-06-19T02:07:01+10:00 http://pharmadispatch.com/news/biotron-says-bit225-011-meets-objectives-in-phase-2-hiv-efficacy-trial 2024-06-19T20:22:01+10:00 http://pharmadispatch.com/news/medicines-australia-urges-caution-on-interpreting-medicine-shortages 2024-06-19T22:44:01+10:00 http://pharmadispatch.com/news/cancer-funding-commitment-did-not-make-it-through-the-budget-processs 2024-06-20T13:00:01+10:00 http://pharmadispatch.com/news/mixed-messaging-drives-confusion-over-cancer-medicines-commitment 2024-06-20T22:30:01+10:00 http://pharmadispatch.com/news/pharmac-was-excluded-because-it-was-the-only-way-to-make-a-credible-commitment 2024-06-20T22:46:01+10:00 http://pharmadispatch.com/news/msd-managing-director-departing-to-leading-the-companys-japan-oncology-business 2024-06-21T13:00:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-21-june 2024-06-21T22:31:01+10:00 http://pharmadispatch.com/news/abbvie-announces-new-leadership-for-its-new-zealand-business 2024-06-24T13:00:01+10:00 http://pharmadispatch.com/news/oncology-leadership-transitions-for-msd-australia-and-zealand 2024-06-23T20:38:01+10:00 http://pharmadispatch.com/news/a-legally-questionable-outcome-but-one-that-reveals-the-truth-of-this-process 2024-06-23T21:16:01+10:00 http://pharmadispatch.com/news/report-suggests-significant-funding-boost-for-pharmac 2024-06-24T13:00:01+10:00 http://pharmadispatch.com/news/joint-submission-recommends-adjustments-to-minimum-stockholding-requirement 2024-06-24T13:00:01+10:00 http://pharmadispatch.com/news/new-survey-reveals-the-struggle-for-patients-living-with-eczema 2024-06-25T13:00:01+10:00 http://pharmadispatch.com/news/imugene-doses-the-first-patient-in-pioneering-phase-1-oncarlytics-trial 2024-06-24T23:17:01+10:00 http://pharmadispatch.com/news/that-the-pbac-cannot-lawfully-condition-its-recommendations-is-a-statement-of-uncontested-fact 2024-06-26T13:00:01+10:00 http://pharmadispatch.com/news/work-underway-after-nz-government-confirms-funding-commitment-for-new-medicines 2024-06-25T13:00:01+10:00 http://pharmadispatch.com/news/a-welcome-commitment-that-shows-the-challenge-of-catch-up-on-access 2024-06-25T13:00:01+10:00 http://pharmadispatch.com/news/senates-expectation-that-community-pharmacies-become-vape-retailers-and-vape-garbage-collectors- 2024-06-25T03:43:01+10:00 http://pharmadispatch.com/news/the-department-has-no-intention-to-disclose-protected-information 2024-06-25T13:51:01+10:00 http://pharmadispatch.com/news/no-time-to-waste-no-more-lives-to-lose-says-genomics-pioneer 2024-06-26T13:00:01+10:00 http://pharmadispatch.com/news/pharmacy-guild-says-no-longer-any-need-to-accept-vaping-amendment 2024-06-26T04:51:01+10:00 http://pharmadispatch.com/news/phrma-says-new-analysis-shows-how-new-pricing-power-will-raise-costs-for-millions 2024-06-27T13:00:01+10:00 http://pharmadispatch.com/news/the-makers-will-be-delighted-these-products-will-be-more-accessible 2024-06-27T12:00:01+10:00 http://pharmadispatch.com/news/pharmacy-groups-lament-parliamentary-support-for-more-accessible-vapes 2024-06-27T13:00:01+10:00 http://pharmadispatch.com/news/parliament-backs-changes-included-in-the-new-community-pharmacy-agreement 2024-06-28T13:00:01+10:00 http://pharmadispatch.com/news/australian-company-reports-topline-results-from-clinical-trial-involving-msds-keytruda 2024-06-28T13:00:01+10:00 http://pharmadispatch.com/news/trailblazers-speakers-with-a-leader-about-their-current-public-campaign 2024-06-28T02:35:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-28-june 2024-06-28T22:29:01+10:00 http://pharmadispatch.com/news/msd-regains-australian-rights-to-supply-and-distribute-its-pneumococcal-vaccine 2024-07-01T13:00:01+10:00 http://pharmadispatch.com/news/sanofis-meningococcal-vaccine-now-funded-for-adolescents 2024-07-01T13:00:01+10:00 http://pharmadispatch.com/news/first-ceo-for-the-sydney-based-viral-vector-manufacturing-facility 2024-07-01T13:00:01+10:00 http://pharmadispatch.com/news/health-products-portal-depreciation-drives-the-above-inflation-fee-increase 2024-07-01T13:00:01+10:00 http://pharmadispatch.com/news/pharma-companies-named-excellence-awardees-in-australian-hr-awards 2024-07-02T13:00:01+10:00 http://pharmadispatch.com/news/apparently-efficiencies-for-the-industry-mean-higher-cost-recovery-fees 2024-07-01T23:12:01+10:00 http://pharmadispatch.com/news/assistant-health-minister-steps-in-to-make-july-pbs-listings 2024-07-02T13:00:01+10:00 http://pharmadispatch.com/news/patients-welcome-ending-the-postcode-lottery-for-access-for-severely-immunocompromised-patients 2024-07-02T13:00:01+10:00 http://pharmadispatch.com/news/flagship-biennial-report-reveals-the-wider-health-impact-of-the-covid-19-pandemic 2024-07-03T13:00:01+10:00 http://pharmadispatch.com/news/professional-standards-and-insurance-risks-key-to-pharmacy-concerns 2024-07-03T13:00:01+10:00 http://pharmadispatch.com/news/medicines-australia-wants-changes-made-to-draft-immunisation-strategy 2024-07-03T13:16:01+10:00 http://pharmadispatch.com/news/clinician-questions-pharmacs-decision-to-fund-old-cancer-medicines-over-newer-options 2024-07-03T13:00:01+10:00 http://pharmadispatch.com/news/patients-gather-in-canberra-to-call-for-access-ahead-of-next-weeks-pbac-meeting 2024-07-04T13:00:01+10:00 http://pharmadispatch.com/news/new-zealand-pharmacies-to-administer-more-childhood-vaccinations 2024-07-04T13:50:01+10:00 http://pharmadispatch.com/news/committee-recommends-major-overhaul-of-diabetes-management-and-access 2024-07-05T13:00:01+10:00 http://pharmadispatch.com/news/csls-gene-therapy-becomes-the-first-funded-via-the-uks-innovative-medicines-fund 2024-07-05T12:00:01+10:00 http://pharmadispatch.com/news/new-report-reveals-strong-growth-in-valuations-of-local-life-science-companies 2024-07-05T13:00:01+10:00 http://pharmadispatch.com/news/mercks-record-support-for-australian-ms-community 2024-07-05T13:00:01+10:00 http://pharmadispatch.com/news/committee-backs-jj-car-t-but-redirects-price-negotiation-with-four-year-proposal 2024-07-08T13:07:01+10:00 http://pharmadispatch.com/news/where-does-the-system-end-if-statements-like-this-become-a-feature-of-our-decision-making 2024-07-08T13:00:01+10:00 http://pharmadispatch.com/news/pharmac-launches-first-consultation-for-medicines-after-funding-boost 2024-07-08T13:00:01+10:00 http://pharmadispatch.com/news/if-this-does-signal-a-new-way-of-communicating-the-industry-does-have-tools-to-deploy 2024-07-09T13:00:01+10:00 http://pharmadispatch.com/news/british-industry-welcomes-new-government-and-its-innovation-and-adoption-strategy 2024-07-09T13:00:01+10:00 http://pharmadispatch.com/news/florey-biotech-spin-out-secures-seed-investment-from-curiebio 2024-07-09T05:24:01+10:00 http://pharmadispatch.com/news/the-simple-option-for-a-bridging-fund-that-can-fit-in-the-existing-legal-framework 2024-07-10T13:00:01+10:00 http://pharmadispatch.com/news/ausbiotech-announces-the-appointment-of-its-new-board-chair 2024-07-10T13:00:01+10:00 http://pharmadispatch.com/news/the-one-upside-of-this-statement-that-should-trigger-the-industry-to-change-the-language 2024-07-10T13:00:01+10:00 http://pharmadispatch.com/news/the-governments-good-conscience-should-extent-to-other-patients-waiting-for-access 2024-07-11T13:23:01+10:00 http://pharmadispatch.com/news/icon-group-expands-into-the-uk-with-acquisition-of-specialist-pharmaceutical-and-healthcare-comp 2024-07-11T13:00:01+10:00 http://pharmadispatch.com/news/pharmac-proposes-investing-more-of-its-recent-funding-boost 2024-07-11T13:00:01+10:00 http://pharmadispatch.com/news/patients-and-families-welcomes-governments-funding-for-neuroblastoma-treatment 2024-07-11T13:00:01+10:00 http://pharmadispatch.com/news/the-new-medicines-manufacturing-innovation-centre-opens-at-monash 2024-07-11T04:32:01+10:00 http://pharmadispatch.com/news/gilead-welcomes-first-regional-car-t-treatment-centre-in-far-north-queensland 2024-07-12T13:00:01+10:00 http://pharmadispatch.com/news/clinician-concern-over-ongoing-shortages-of-end-of-life-medicines 2024-07-11T21:18:01+10:00 http://pharmadispatch.com/news/telix-welcomes-cms-proposal-to-improve-payment-for-specialised-diagnostic-radiopharmaceuticals 2024-07-12T03:09:01+10:00 http://pharmadispatch.com/news/zelira-says-it-advances-hope-autism-drug-program-with-us-fda-meeting 2024-07-12T03:10:01+10:00 http://pharmadispatch.com/news/orthocell-receives-regulatory-approval-to-commence-sales-of-striate-in-canada 2024-07-12T03:12:01+10:00 http://pharmadispatch.com/news/medicines-australia-says-recent-events-demonstrate-the-need-for-change 2024-07-12T15:07:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-12-july 2024-07-12T22:38:01+10:00 http://pharmadispatch.com/news/merck-expands-its-fertility-benefit-to-employees-in-new-zealand 2024-07-15T13:00:01+10:00 http://pharmadispatch.com/news/a-strategic-acquisition-that-was-almost-six-years-in-the-making-says-icon-groups-david-slade 2024-07-14T20:57:01+10:00 http://pharmadispatch.com/news/australian-company-reports-positive-results-from-combination-trial-of-cancer-therapy 2024-07-14T23:10:01+10:00 http://pharmadispatch.com/news/pharmac-announces-third-funding-proposal-in-response-to-recent-post-budget-boost 2024-07-15T13:00:01+10:00 http://pharmadispatch.com/news/diabetes-australia-wants-expanded-access-to-cgm-and-insulin-pumps 2024-07-15T20:02:01+10:00 http://pharmadispatch.com/news/it-is-worth-knowing-the-criteria-used-to-justify-the-creation-of-the-dfmo-bridging-fund 2024-07-16T13:00:01+10:00 http://pharmadispatch.com/news/bio-innovation-hub-opens-opportunities-for-new-disease-treatments 2024-07-16T13:00:01+10:00 http://pharmadispatch.com/news/recently-established-company-joins-the-generic-and-biosimilar-medicines-association 2024-07-16T20:18:01+10:00 http://pharmadispatch.com/news/pharmac-minister-david-seymour-sets-our-the-governments-reform-agenda 2024-07-17T13:00:01+10:00 http://pharmadispatch.com/news/moderna-welcomes-federal-governments-new-rna-blueprint 2024-07-17T13:00:01+10:00 http://pharmadispatch.com/news/how-can-it-be-fair-that-patients-are-denied-access-to-proven-treatments-while-the-government-fun 2024-07-18T13:00:01+10:00 http://pharmadispatch.com/news/queensland-based-de-motu-cordis-progresses-development-inhaled-anaphylaxis-treatment 2024-07-18T13:00:01+10:00 http://pharmadispatch.com/news/burnet-senior-research-officer-awarded-moderna-global-fellowship-2023 2024-07-18T13:00:01+10:00 http://pharmadispatch.com/news/alterity-therapeutics-reports-positive-interim-data-from-multiple-system-atrophy-trial 2024-07-18T13:00:01+10:00 http://pharmadispatch.com/news/gilead-welcomes-car-t-outcome-and-anticipates-price-negotiation 2024-07-18T13:00:01+10:00 http://pharmadispatch.com/news/no-agreement-required-to-deliver-early-patient-access-to-neuroblastoma-treatment 2024-07-19T13:00:01+10:00 http://pharmadispatch.com/news/the-combination-of-political-will-and-trust-paving-the-way-forward-on-access 2024-07-19T13:00:01+10:00 http://pharmadispatch.com/news/pink-hope-ceo-discussed-her-own-experience-and-journey-with-trailblazers 2024-07-19T02:05:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-19-july 2024-07-19T21:43:01+10:00 http://pharmadispatch.com/news/australian-icon-ita-buttrose-champions-new-rsv-awareness-campaign 2024-07-22T13:00:01+10:00 http://pharmadispatch.com/news/it-is-the-institution-that-needs-reforming-not-the-process-of-technical-inputs 2024-07-21T19:45:01+10:00 http://pharmadispatch.com/news/medicines-australia-to-host-roundtable-aiming-to-drive-hta-reform 2024-07-22T13:00:01+10:00 http://pharmadispatch.com/news/we-were-promised-an-independent-review-and-this-is-what-we-got 2024-07-23T13:00:01+10:00 http://pharmadispatch.com/news/viatris-sylvain-vigneault-on-the-importance-of-touch-points-with-the-community 2024-07-23T01:37:01+10:00 http://pharmadispatch.com/news/hcf-research-foundation-hosts-roundtable-to-advance-short-stay-joint-replacements 2024-07-23T05:08:01+10:00 http://pharmadispatch.com/news/chimeric-therapeutics-says-first-patient-dosed-in-cell-therapy-trial 2024-07-23T15:25:01+10:00 http://pharmadispatch.com/news/uk-moves-quickly-to-establish-rsv-vaccination-program-ahead-of-winter 2024-07-23T13:00:01+10:00 http://pharmadispatch.com/news/the-dispatched-podcast-special-edition 2024-07-24T02:47:01+10:00 http://pharmadispatch.com/news/centre-for-sex-and-gender-equity-in-health-and-medicine-confirms-leadership 2024-07-24T04:39:01+10:00 http://pharmadispatch.com/news/new-large-study-shows-vaccination-halves-the-risk-of-patients-suffering-long-covid 2024-07-25T13:00:01+10:00 http://pharmadispatch.com/news/these-layered-levels-of-privilege-are-not-making-decision-making-or-the-system-better 2024-07-25T13:00:01+10:00 http://pharmadispatch.com/news/telix-completes-significant-raise-that-could-be-used-for-acquistions 2024-07-25T13:00:01+10:00 http://pharmadispatch.com/news/we-approached-stakeholders-that-were-highly-engaged-with-the-hta-review-process 2024-07-26T13:00:01+10:00 http://pharmadispatch.com/news/it-is-a-mistake-to-preach-transparency-but-not-practice-it 2024-07-26T13:00:01+10:00 http://pharmadispatch.com/news/cartherics-announces-new-licensing-agreement-for-innovative-cardiac-cell-therapy 2024-07-26T05:00:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-26-july 2024-07-26T21:31:01+10:00 http://pharmadispatch.com/news/the-one-upside-is-the-opportunity-to-prepare-for-likely-response 2024-07-29T13:00:01+10:00 http://pharmadispatch.com/news/start-planning-for-a-change-that-would-further-entrench-decision-making-power 2024-07-29T13:00:01+10:00 http://pharmadispatch.com/news/monash-welcomes-funding-for-new-national-centre-for-mrna-medicines 2024-07-29T13:00:01+10:00 http://pharmadispatch.com/news/bms-says-it-is-increasingly-confident-of-managing-the-impact-of-us-price-negotiation 2024-07-29T13:00:01+10:00 http://pharmadispatch.com/news/progress-towards-our-mission-of-providing-a-treatment-for-all-people-living-with-cf 2024-07-29T20:13:01+10:00 http://pharmadispatch.com/news/radiopharm-theranostics-targets-nasdaq-listing-by-end-of-2024 2024-07-29T20:47:01+10:00 http://pharmadispatch.com/news/nothing-but-sorrow-for-the-price-people-are-willing-to-pay-to-be-part-of-this-institution 2024-07-30T13:00:01+10:00 http://pharmadispatch.com/news/race-oncology-says-phase-2-trial-of-bisantrene-meets-predetermined-efficacy-criteria 2024-07-30T19:25:01+10:00 http://pharmadispatch.com/news/uncertain-timeline-on-hta-review-outcome-pbac-to-consider-report-in-coming-months 2024-07-30T20:35:01+10:00 http://pharmadispatch.com/news/youll-never-guess-how-many-people-signed-hta-review-non-disclosure-agreements 2024-07-30T13:00:01+10:00 http://pharmadispatch.com/news/pharmaceutical-manufacturer-tops-revenue-guidance-in-latest-update 2024-07-31T13:00:01+10:00 http://pharmadispatch.com/news/companies-welcome-updated-pbs-prescribing-criteria-for-sglt-2-inhibitor-therapy 2024-08-01T13:00:01+10:00 http://pharmadispatch.com/news/first-immunotherapy-based-neoadjuvant-treatment-for-resectable-non-small-cell-lung-cancer-is-now 2024-08-01T13:00:01+10:00 http://pharmadispatch.com/news/government-funds-first-immunotherapy-subcutaneous-injection-via-the-pbs 2024-08-01T13:05:01+10:00 http://pharmadispatch.com/news/breakthrough-pbs-listing-for-emergency-treatment-of-life-threatening-seizures 2024-08-01T13:00:01+10:00 http://pharmadispatch.com/news/november-pbac-to-consider-major-new-listings-and-significant-biosimilar 2024-08-01T13:00:01+10:00 http://pharmadispatch.com/news/ipsen-and-patients-welcome-new-pbs-listing-for-thyroid-cancer 2024-08-02T13:00:01+10:00 http://pharmadispatch.com/news/pan-tumour-precision-medicine-funded-for-brain-lung-and-soft-tissue-cancers-with-genetic-fault 2024-08-02T13:00:01+10:00 http://pharmadispatch.com/news/the-governments-response-to-this-royal-commission-complicates-hta-reform 2024-08-02T13:00:01+10:00 http://pharmadispatch.com/news/peter-malinauskas-congratulates-bellberry-on-20-year-anniversary 2024-08-02T03:31:01+10:00 http://pharmadispatch.com/news/novo-nordisk-says-glp-1-now-available-on-private-prescription-for-weight-loss 2024-08-02T14:59:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-2-august 2024-08-02T21:18:01+10:00 http://pharmadispatch.com/news/an-admission-on-the-process-that-should-lead-to-the-most-obvious-solution 2024-08-05T13:00:01+10:00 http://pharmadispatch.com/news/it-took-16-months-but-this-pricing-quirk-has-been-resolved 2024-08-05T13:00:01+10:00 http://pharmadispatch.com/news/psa-launches-its-updated-vision-documents-with-expanded-focus-areas 2024-08-05T13:00:01+10:00 http://pharmadispatch.com/news/the-process-does-not-cause-delays-it-promotes-them 2024-08-05T20:58:01+10:00 http://pharmadispatch.com/news/pharmac-proposes-funding-additional-treatments-for-bowel-cancer 2024-08-06T02:22:01+10:00 http://pharmadispatch.com/news/ausbiotech-announces-the-appointment-of-deputy-chief-executive 2024-08-06T13:00:01+10:00 http://pharmadispatch.com/news/csl-seqirus-and-st-john-ambulance-launch-potentially-life-saving-partnership 2024-08-06T13:38:01+10:00 http://pharmadispatch.com/news/abbvie-joins-other-organisations-in-the-franklin-women-wikipedia-edit-a-thon 2024-08-07T13:00:01+10:00 http://pharmadispatch.com/news/amgen-australia-announces-partnerships-aimed-at-improving-aboriginal-and-torres-strait-islander- 2024-08-07T13:00:01+10:00 http://pharmadispatch.com/news/pfizer-upgrades-melbourne-plant-making-it-one-of-the-most-advanced-facilities-in-australia 2024-08-07T13:00:01+10:00 http://pharmadispatch.com/news/some-groups-are-willing-to-resist-the-confidentiality-madness 2024-08-08T13:00:01+10:00 http://pharmadispatch.com/news/australian-company-islands-progresses-trial-of-dengue-fever-candidate 2024-08-08T13:00:01+10:00 http://pharmadispatch.com/news/hta-review-report-could-be-released-ahead-of-the-governments-full-response 2024-08-08T13:00:01+10:00 http://pharmadispatch.com/news/people-are-living-longer-but-they-do-so-from-the-shadows-rarely-visible-and-barely-heard 2024-08-08T13:00:01+10:00 http://pharmadispatch.com/news/the-week-in-review-8-august 2024-08-09T03:13:01+10:00 http://pharmadispatch.com/news/researchers-develop-ground-breaking-immunotherapy-for-aggressive-brain-cancer 2024-08-09T03:00:01+10:00 http://pharmadispatch.com/news/patients-in-england-gain-funded-access-to-gene-editing-therapy 2024-08-09T13:00:01+10:00 http://pharmadispatch.com/news/gsk-announces-new-leadership-for-australian-operation 2024-08-12T13:00:01+10:00 http://pharmadispatch.com/news/we-think-the-life-sciences-sector-should-be-central-to-our-national-growth 2024-08-12T13:00:01+10:00 http://pharmadispatch.com/news/the-industry-has-leverage-just-dont-be-tricked-into-giving-it-away-again 2024-08-11T21:34:01+10:00 http://pharmadispatch.com/news/mixed-news-for-neuren-but-royalties-and-milestones-continue-growing 2024-08-11T23:29:01+10:00 http://pharmadispatch.com/news/our-mission-is-to-transform-the-lives-of-people-impacted-by-rare-diseases 2024-08-12T13:00:01+10:00 http://pharmadispatch.com/news/report-suggest-a-delay-in-accc-decision-on-sigma-cw-merger 2024-08-13T13:00:01+10:00 http://pharmadispatch.com/news/cell-therapy-company-chimeric-announces-collaboration-with-cell-therapies 2024-08-13T13:00:01+10:00 http://pharmadispatch.com/news/the-surprises-are-already-coming-and-more-is-likely-to-follow 2024-08-14T13:00:01+10:00 http://pharmadispatch.com/news/the-future-price-impact-could-come-down-to-the-timing-and-order-of-the-listings 2024-08-14T13:00:01+10:00 http://pharmadispatch.com/news/moderna-welcomes-the-governments-national-science-statement 2024-08-14T13:00:01+10:00 http://pharmadispatch.com/news/csl-reports-strong-profit-growth-for-full-year-2024 2024-08-14T03:01:01+10:00 http://pharmadispatch.com/news/new-lilly-backed-report-calls-for-broad-action-in-the-fight-against-obesity 2024-08-15T13:00:01+10:00 http://pharmadispatch.com/news/ausbiotech-selected-as-partner-organisation-for-industry-growth-program 2024-08-14T22:00:01+10:00 http://pharmadispatch.com/news/we-are-heartbroken-and-devastated-by-the-passing-of-our-well-loved-and-respected-colleague 2024-08-15T13:00:01+10:00 http://pharmadispatch.com/news/achieving-consensus-around-platform-approaches-is-both-urgent-and-important 2024-08-16T13:00:01+10:00 http://pharmadispatch.com/news/modernas-carolyn-tucek-szabo-on-the-opportunities-and-efficiencies-of-a-platform-approach 2024-08-16T13:00:01+10:00 http://pharmadispatch.com/news/iriss-positive-impact-on-australias-biotech-ecosystem-will-be-felt-for-decades-to-come 2024-08-16T13:00:01+10:00 http://pharmadispatch.com/news/first-ten-medicines-subject-to-pricing-power-to-take-reductions-of-up-to-79-per-cent 2024-08-16T15:04:01+10:00 http://pharmadispatch.com/news/the-week-in-review-dispatched-podcast-16-august 2024-08-16T21:10:01+10:00 http://pharmadispatch.com/news/a-cautious-response-will-protect-your-position-for-the-inevitable-negotiation 2024-08-19T13:00:01+10:00 http://pharmadispatch.com/news/australian-company-welcomes-fda-approval-of-needle-free-anaphylaxis-treatment 2024-08-19T13:00:01+10:00 http://pharmadispatch.com/news/one-audit-on-the-pbs-might-be-followed-by-another-on-procurement-and-capability 2024-08-19T13:00:01+10:00 http://pharmadispatch.com/news/rare-cancer-advocate-and-survivor-recognised-with-national-accolade 2024-08-19T19:55:01+10:00 http://pharmadispatch.com/news/noxopharm-targets-clinical-trial-for-first-in-class-investigative-therapy 2024-08-19T20:59:01+10:00 http://pharmadispatch.com/news/a-meaningless-measure-that-distracts-from-the-already-identified-cause-of-delays 2024-08-20T13:00:01+10:00 http://pharmadispatch.com/news/australias-child-vaccination-rates-are-world-leading-our-adult-rates-are-not 2024-08-19T22:34:01+10:00 http://pharmadispatch.com/news/weve-had-the-conversationsnow-is-the-time-for-decisive-action 2024-08-20T13:00:01+10:00 http://pharmadispatch.com/news/trailblazers-speaks-with-professor-fran-boyle-about-out-from-the-shadows 2024-08-20T03:11:01+10:00 http://pharmadispatch.com/news/without-action-the-recommendations-will-just-remain-as-words-on-a-page 2024-08-20T21:18:01+10:00 http://pharmadispatch.com/news/if-these-are-the-solutions-the-minister-might-question-the-extent-of-the-problem 2024-08-20T21:50:01+10:00 http://pharmadispatch.com/news/omico-launches-national-educational-cancer-and-genomics-initiative 2024-08-21T13:16:01+10:00 http://pharmadispatch.com/news/msd-announces-its-new-leadership-for-australia-and-new-zealand 2024-08-21T13:00:01+10:00 http://pharmadispatch.com/news/queensland-researchers-identify-potential-new-treatment-pathway-for-bladder-cancer 2024-08-21T20:22:01+10:00 http://pharmadispatch.com/news/bioxynedelivers-australias-first-pharmaceutical-cannabis-gummies 2024-08-21T20:52:01+10:00 http://pharmadispatch.com/news/new-zealands-pharmac-proposes-funding-heart-failure-medicine 2024-08-22T13:00:01+10:00 http://pharmadispatch.com/news/tga-approves-the-first-targeted-radioligand-therapy-for-advanced-prostate-cancer 2024-08-22T13:00:01+10:00 http://pharmadispatch.com/news/we-hope-to-be-able-to-make-a-difference-and-pave-the-way-for-some-of-australias-future-health-le 2024-08-22T13:00:01+10:00 http://pharmadispatch.com/news/arthritis-australia-calls-for-improved-access-to-care-to-reduct-the-risk-of-surgeries 2024-08-22T13:00:01+10:00 http://pharmadispatch.com/news/a-post-covid-transition-period-for-the-company-as-it-returns-to-business-as-usual 2024-08-23T13:00:01+10:00 http://pharmadispatch.com/news/government-moves-quickly-to-clarify-pricing-legislation-following-federal-court-victory 2024-08-23T13:00:01+10:00 http://pharmadispatch.com/news/biogen-marks-the-tenth-anniversary-of-als-ice-bucket-challenge 2024-08-23T02:17:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-22-august 2024-08-23T04:53:01+10:00 http://pharmadispatch.com/news/abbvie-australia-makes-the-list-of-best-places-to-work-for-11th-year 2024-08-23T15:13:01+10:00 http://pharmadispatch.com/news/the-government-can-demonstrate-that-its-support-for-womens-health-is-more-than-talk 2024-08-26T13:00:01+10:00 http://pharmadispatch.com/news/this-is-in-stark-contrast-to-other-parts-of-the-world-where-new-rsv-immunisations-have-been-read 2024-08-26T13:00:01+10:00 http://pharmadispatch.com/news/july-outcomes-disappoint-but-committee-appears-to-relent-on-risk-share-arrangement 2024-08-26T13:00:01+10:00 http://pharmadispatch.com/news/more-formal-scrutiny-is-the-obvious-consequence-of-a-broader-role 2024-08-27T13:00:01+10:00 http://pharmadispatch.com/news/archies-embrace-funds-australian-research-into-rare-genetic-disorder 2024-08-26T21:23:01+10:00 http://pharmadispatch.com/news/radiopharm-theranostics-increases-ownership-in-jointly-owned-venture-firm 2024-08-26T22:12:01+10:00 http://pharmadispatch.com/news/chp-celebrates-50-years-of-growth-and-contributing-to-better-health-outcomes 2024-08-26T22:26:01+10:00 http://pharmadispatch.com/news/nzs-health-minister-says-funding-boost-is-supporting-higher-immunisation-rates 2024-08-26T22:44:01+10:00 http://pharmadispatch.com/news/pharmaust-says-reports-positive-interim-study-results-from-study-in-als 2024-08-26T23:56:01+10:00 http://pharmadispatch.com/news/the-commonwealth-saving-the-states-from-their-terrible-decisions-again 2024-08-28T03:04:01+10:00 http://pharmadispatch.com/news/sandoz-welcomes-regulatory-approval-for-the-first-denosumab-biosimilar-in-australia 2024-08-28T03:37:01+10:00 http://pharmadispatch.com/news/medicines-australia-election-process-well-an-truly-underway 2024-08-28T13:00:01+10:00 http://pharmadispatch.com/news/hospital-pharmacy-is-no-longer-contained-by-the-four-walls-of-our-hospitals 2024-08-28T19:49:01+10:00 http://pharmadispatch.com/news/monash-researchers-developing-finger-prick-test-to-screen-for-early-alzheimers 2024-08-28T20:08:01+10:00 http://pharmadispatch.com/news/we-will-continue-to-advocate-for-earlier-faster-fairer-access-to-medicines-for-the-benefit-of-al 2024-08-29T13:11:01+10:00 http://pharmadispatch.com/news/i-dont-pretend-this-is-going-to-be-an-overnight-thing-really-this-generational-review-to-build-a 2024-08-29T13:00:01+10:00 http://pharmadispatch.com/news/chimeric-says-first-patient-dosed-in-trial-of-cdh17-directed-car-t-cell-therapy 2024-08-29T01:58:01+10:00 http://pharmadispatch.com/news/organon-confirms-new-leadership-for-australia-and-new-zealand 2024-08-29T13:00:01+10:00 http://pharmadispatch.com/news/ausbiotech-has-announced-the-appointment-of-two-senior-executives 2024-08-30T13:00:01+10:00 http://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-30-august 2024-08-30T03:11:01+10:00 http://pharmadispatch.com/news/pharmac-to-fund-continuous-glucose-monitors-from-1-october 2024-08-30T03:27:01+10:00 http://pharmadispatch.com/news/stakeholders-welcome-broader-reimbursement-of-ipsen-cancer-therapy 2024-09-02T13:00:01+10:00 http://pharmadispatch.com/news/tasmania-to-override-federal-law-with-ban-on-otc-vape-sales 2024-09-02T13:05:01+10:00 http://pharmadispatch.com/news/minister-welcomes-third-tranche-of-60-day-medicines-as-patient-group-urges-caution 2024-09-02T13:00:01+10:00 http://pharmadispatch.com/news/initial-guidance-on-parameters-that-need-to-be-considered-for-future-broad-pbs-listing-proposals 2024-09-01T23:08:01+10:00 http://pharmadispatch.com/news/trailblazers-marks-prostate-cancer-awareness-month-this-september 2024-09-02T00:46:01+10:00 http://pharmadispatch.com/news/wehi-says-cutting-edge-immunotherapy-could-hold-promise-for-incurable-brain-cancer 2024-09-02T19:22:01+10:00 http://pharmadispatch.com/news/senate-inquiry-recommends-the-government-explore-a-broader-vaccine-compensation-scheme 2024-09-03T13:00:01+10:00 http://pharmadispatch.com/news/emyria-announces-interim-clinical-trial-results-for-ptsd-program 2024-09-03T00:15:01+10:00 http://pharmadispatch.com/news/race-oncology-announces-the-detail-of-first-phase-of-board-renewal 2024-09-03T00:25:01+10:00 http://pharmadispatch.com/news/mtpconnect-launches-industry-backed-accelerator-investment-program 2024-09-03T02:25:01+10:00 http://pharmadispatch.com/news/the-decision-making-process-is-generally-complicated-contested-and-slow 2024-09-04T13:00:01+10:00 http://pharmadispatch.com/news/lowering-co-pay-11-times-more-effective-for-cost-of-living-relief-than-increased-quantities 2024-09-03T21:49:01+10:00 http://pharmadispatch.com/news/the-annual-publication-of-budget-rules-provides-a-historically-unique-insight 2024-09-04T00:18:01+10:00 http://pharmadispatch.com/news/merck-introduces-greener-solutions-for-cold-chain-shipments-in-australia 2024-09-04T01:34:01+10:00 http://pharmadispatch.com/news/government-still-working-towards-first-formal-agreement-with-wholesalers 2024-09-05T13:00:01+10:00 http://pharmadispatch.com/news/australian-patients-part-of-global-push-for-personalised-care-solution 2024-09-05T13:00:01+10:00 http://pharmadispatch.com/news/groups-collaborate-on-the-development-of-new-opioid-safety-toolkit 2024-09-05T14:56:01+10:00 http://pharmadispatch.com/news/an-increasingly-busy-agenda-risks-squeezing-out-other-issues 2024-09-05T20:35:01+10:00 http://pharmadispatch.com/news/patients-welcome-wider-access-to-shingles-vaccine-for-immunocompromised-patients 2024-09-06T13:00:01+10:00 http://pharmadispatch.com/news/pfizer-backed-initiative-boosts-aboriginal-and-torres-strait-islander-pharmacy-leadership 2024-09-06T02:16:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-6-september 2024-09-06T04:20:01+10:00 http://pharmadispatch.com/news/csl-announces-sale-of-wuhan-plasma-collection-and-fractionation-operations 2024-09-06T04:33:01+10:00 http://pharmadispatch.com/news/over-20-groups-join-arthritis-australias-call-for-urgent-action-on-arthritis-and-musculoskeletal 2024-09-08T19:30:01+10:00 http://pharmadispatch.com/news/moderna-australia-celebrates-regional-research-centres-first-12-months 2024-09-08T19:48:01+10:00 http://pharmadispatch.com/news/new-us-government-report-upends-the-claims-of-intellectual-property-critics 2024-09-09T13:00:01+10:00 http://pharmadispatch.com/news/ena-respiratory-secures-extension-of-us-funding-for-novel-prophylactic-antiviral 2024-09-08T20:27:01+10:00 http://pharmadispatch.com/news/be-clear-eye-about-whatever-trade-off-the-institution-demands-you-accept 2024-09-10T13:00:01+10:00 http://pharmadispatch.com/news/rare-cancers-australia-and-australian-genomics-to-host-policy-roundtable 2024-09-10T13:00:01+10:00 http://pharmadispatch.com/news/pharmac-announces-first-cancer-medicine-decision-after-funding-boost 2024-09-10T00:39:01+10:00 http://pharmadispatch.com/news/new-report-reveals-australia-is-blind-to-the-leading-cause-of-vision-loss 2024-09-11T13:00:01+10:00 http://pharmadispatch.com/news/dimerix-announces-that-first-patient-enters-dmx-200-open-label-extension 2024-09-10T20:38:01+10:00 http://pharmadispatch.com/news/biotron-updates-on-bit225-012-phase-2-covid-19-clinical-trial 2024-09-09T21:06:01+10:00 http://pharmadispatch.com/news/first-ever-study-of-family-linked-cancer-reveals-skyrocketing-financial-and-emotional-toll 2024-09-11T13:00:01+10:00 http://pharmadispatch.com/news/full-credit-for-the-honesty-but-this-is-pharmac-and-not-even-in-disguise 2024-09-11T06:24:01+10:00 http://pharmadispatch.com/news/this-report-prioritises-therapies-that-deliver-government-savings-over-those-that-benefit-patien 2024-09-11T13:08:01+10:00 http://pharmadispatch.com/news/this-enthusiastic-response-is-acceptance-of-changes-to-deliver-billions-in-new-savings 2024-09-11T19:56:01+10:00 http://pharmadispatch.com/news/in-236-pages-this-one-section-captures-the-primary-barrier-to-real-reform 2024-09-13T13:00:01+10:00 http://pharmadispatch.com/news/pharmaprograms-announces-extension-of-long-standing-partnership-with-nostradata 2024-09-12T13:00:01+10:00 http://pharmadispatch.com/news/tga-extends-approval-for-eli-lillys-diabetes-therapy-to-include-weight-management 2024-09-11T22:58:01+10:00 http://pharmadispatch.com/news/this-single-proposal-could-be-the-single-biggest-destruction-of-therapeutic-value 2024-09-12T01:00:01+10:00 http://pharmadispatch.com/news/brandon-biocatalysts-cureator-incubator-boosts-preclinical-and-health-security-innovations-with- 2024-09-12T01:35:01+10:00 http://pharmadispatch.com/news/telixs-phase-3-zircon-trial-for-kidney-cancer-imaging-published-in-the-lancet-oncology 2024-09-12T02:19:01+10:00 http://pharmadispatch.com/news/hta-review-will-achieve-savings-but-it-wont-achieve-better-access-for-all 2024-09-12T15:05:01+10:00 http://pharmadispatch.com/news/it-is-never-too-late-for-a-considered-response-caution 2024-09-13T13:00:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-13-september 2024-09-13T04:24:01+10:00 http://pharmadispatch.com/news/a-statement-with-intent-that-limits-expectations-and-frames-policy-discussions 2024-09-16T13:00:01+10:00 http://pharmadispatch.com/news/the-hta-review-report-and-red-flag-number-one-of-five 2024-09-16T13:00:01+10:00 http://pharmadispatch.com/news/australian-company-kazia-executes-licensing-agreement-with-qimr-berghofer 2024-09-16T13:06:01+10:00 http://pharmadispatch.com/news/pharmac-announces-plan-to-deploy-more-of-its-recent-funding-boost 2024-09-16T13:00:01+10:00 http://pharmadispatch.com/news/the-hta-review-report-red-flag-number-two-of-five 2024-09-16T20:07:01+10:00 http://pharmadispatch.com/news/medicines-australia-responds-to-questions-on-the-hta-review 2024-09-17T08:27:01+10:00 http://pharmadispatch.com/news/immutep-says-it-candidate-in-combination-with-keytruda-delivered-positive-efficacy-and-safety-pr 2024-09-17T08:34:01+10:00 http://pharmadispatch.com/news/the-hta-review-report-red-flag-number-three-of-five 2024-09-17T20:28:01+10:00 http://pharmadispatch.com/news/medicines-australia-unveils-next-phase-of-stronger-pbs-campaign 2024-09-18T03:46:01+10:00 http://pharmadispatch.com/news/wesfarmers-health-announces-plan-to-build-new-fulfilment-centre-in-cairns 2024-09-18T04:07:01+10:00 http://pharmadispatch.com/news/the-hta-review-report-red-flag-number-four-of-five 2024-09-18T20:24:01+10:00 http://pharmadispatch.com/news/pharmac-continues-to-invest-its-post-budget-funding-boost 2024-09-19T03:51:01+10:00 http://pharmadispatch.com/news/ausbiotech-pays-tribute-to-a-leading-figure-in-the-creation-of-australias-biotech-sector 2024-09-19T04:14:01+10:00 http://pharmadispatch.com/news/clear-political-leadership-delivers-greeen-shoots-in-new-zealand 2024-09-19T06:40:01+10:00 http://pharmadispatch.com/news/the-hta-review-red-flag-number-five-of-five 2024-09-20T13:00:01+10:00 http://pharmadispatch.com/news/a-way-forward-is-an-opportunity-to-avoid-the-pitfalls-of-previous-processes 2024-09-20T13:00:01+10:00 http://pharmadispatch.com/news/the-dispatched-week-in-review-20-september 2024-09-20T06:10:01+10:00 http://pharmadispatch.com/news/logical-to-gather-more-information-because-of-the-legal-liability-for-decisions 2024-09-23T13:00:01+10:00 http://pharmadispatch.com/news/parliament-backs-government-move-to-clarify-pricing-legislation 2024-09-23T13:00:01+10:00 http://pharmadispatch.com/news/minister-confirms-expanded-funded-access-to-gsks-shingles-vaccine 2024-09-23T14:44:01+10:00 http://pharmadispatch.com/news/directors-need-to-protect-themselves-and-medicines-australia-needs-to-protects-it-directors 2024-09-24T13:00:01+10:00 http://pharmadispatch.com/news/auditor-general-extends-time-for-pbs-performance-audit 2024-09-24T13:00:01+10:00 http://pharmadispatch.com/news/telix-to-acquire-north-american-manufacturing-and-distribution-platform 2024-09-24T13:00:01+10:00 http://pharmadispatch.com/news/an-opportunity-to-act-quickly-to-implement-a-netflix-style-subscription-model-for-antibiotics 2024-09-25T13:00:01+10:00 http://pharmadispatch.com/news/as-a-director-it-is-akin-to-one-company-negotiating-the-listing-of-a-competitors-product 2024-09-25T13:00:01+10:00 http://pharmadispatch.com/news/gilead-tops-patient-group-reputation-survey 2024-09-25T14:58:01+10:00 http://pharmadispatch.com/news/members-should-demand-more-power-and-directors-should-embrace-it 2024-09-26T13:00:01+10:00 http://pharmadispatch.com/news/organon-medical-director-says-its-time-to-take-a-stand-against-online-misinformation 2024-09-26T13:00:01+10:00 http://pharmadispatch.com/news/painaustralia-new-chief-executive-to-succeed-giulia-jones 2024-09-26T13:00:01+10:00 http://pharmadispatch.com/news/the-week-in-review-podcast-27-september 2024-09-27T13:00:01+10:00 http://pharmadispatch.com/news/giving-back-is-part-of-our-dna-at-vertex-and-something-we-are-all-very-passionate-about 2024-09-27T13:00:01+10:00 http://pharmadispatch.com/news/gilead-continues-support-for-health-equity-through-2024-community-grants-program 2024-09-27T13:00:01+10:00 http://pharmadispatch.com/news/ucb-confirms-expanded-listing-for-for-severe-psoriatic-arthritis-and-axial-spondyloarthritis 2024-10-01T13:00:01+10:00 http://pharmadispatch.com/news/magentus-partners-with-amgen-australia-to-deliver-ai-powered-dermatology-tool 2024-09-27T14:53:01+10:00 http://pharmadispatch.com/news/good-to-be-inside-the-tent-but-first-make-sure-its-safe-to-enter 2024-09-30T13:00:01+10:00 http://pharmadispatch.com/news/csl-welcomes-scientific-community-to-australia-for-global-influenza-conference 2024-09-30T13:00:01+10:00 http://pharmadispatch.com/news/real-life-lady-garden-implores-women-to-put-their-health-first 2024-09-30T13:00:01+10:00 http://pharmadispatch.com/news/bellberry-wins-championing-health-in-telstra-business-awards 2024-09-30T13:00:01+10:00 http://pharmadispatch.com/news/budget-outcome-confirms-pharmaceutical-spending-topped-20-billion-for-the-first-time 2024-09-30T19:30:01+10:00 http://pharmadispatch.com/news/artrya-submits-application-for-salix-to-the-us-fda 2024-09-30T20:28:01+10:00 http://pharmadispatch.com/news/government-funds-new-dosage-of-eylea-for-common-eye-diseases 2024-10-01T13:00:01+10:00 http://pharmadispatch.com/news/government-funds-jjs-new-combination-blood-cancer-treatment 2024-10-01T13:00:01+10:00 http://pharmadispatch.com/news/organon-welcomes-pbs-listing-of-first-citrate-free-adalimumab-biosimilar 2024-10-01T13:00:01+10:00 http://pharmadispatch.com/news/pfizers-velsipity-pbs-listed-for-people-with-moderately-to-severely-active-ulcerative-colitis 2024-10-01T13:00:01+10:00 http://pharmadispatch.com/news/polynovo-announces-the-retirement-of-long-term-non-executive-director 2024-10-01T02:17:01+10:00 http://pharmadispatch.com/news/mesoblast-option-to-issue-up-to-us50-million-convertible-notes-for-product-launch 2024-10-01T02:27:01+10:00 http://pharmadispatch.com/news/percheron-therapeutics-updates-of-avicursen-primate-toxicology-study 2024-10-01T03:07:01+10:00 http://pharmadispatch.com/news/trent-twomey-secures-second-term-as-pharmacy-guild-national-president 2024-10-01T03:50:01+10:00 http://pharmadispatch.com/news/medicines-australia-strikes-cautious-tone-on-hta-review-implementation-group 2024-10-02T13:12:01+10:00 http://pharmadispatch.com/news/abbvie-heads-the-list-of-australias-best-workplaces-in-pharma-and-biotech 2024-10-02T13:00:01+10:00 http://pharmadispatch.com/news/sigma-offers-court-enforceable-undertaking-in-response-to-accc-concerns 2024-10-02T13:00:01+10:00 http://pharmadispatch.com/news/pfizer-renews-commitment-to-all-patients-during-fourth-annual-patient-week 2024-10-02T13:00:01+10:00 http://pharmadispatch.com/news/omico-welcomes-multi-year-collaboration-with-tessellate-bio-and-cmri-on-alt-cancers 2024-10-02T03:02:01+10:00 http://pharmadispatch.com/news/nyradas-says-lead-drug-candidate-demonstrates-significant-cardioprotection 2024-10-02T03:42:01+10:00 http://pharmadispatch.com/news/cartherics-raises-over-15-million-in-private-financing-round 2024-10-02T03:49:01+10:00 http://pharmadispatch.com/news/australian-company-vaxxas-receives-significant-investment-from-endpoints-capital 2024-10-02T03:55:01+10:00 http://pharmadispatch.com/news/new-partnership-aims-to-build-a-unified-approach-to-delivery-of-australian-cancer-plan 2024-10-02T23:32:01+10:00 http://pharmadispatch.com/news/pharmac-launches-the-rollout-of-medicines-funded-under-budget-boost 2024-10-02T23:42:01+10:00 http://pharmadispatch.com/news/when-it-comes-to-next-steps-on-the-hta-review-its-under-consideration 2024-10-03T13:00:01+10:00 http://pharmadispatch.com/news/the-significant-driver-of-growth-is-the-dramatic-shift-to-free-pbs-prescriptions 2024-10-03T20:18:01+10:00 http://pharmadispatch.com/news/rare-disease-company-sobi-appoints-new-general-manager-for-australia-and-new-zealand 2024-10-04T00:43:01+10:00 http://pharmadispatch.com/news/womens-health-collaboration-calls-for-mbs-reform-to-improve-access-to-contraceptive-choice 2024-10-04T02:17:01+10:00 http://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-4-october 2024-10-04T02:39:01+10:00 http://pharmadispatch.com/news/otsuka-celebrates-its-tenth-anniversary-in-australia 2024-10-04T13:00:01+10:00 http://pharmadispatch.com/news/the-consistent-failure-to-speak-out-is-degrading-this-critical-public-health-program 2024-10-08T14:00:01+11:00 http://pharmadispatch.com/news/island-pharmaceuticals-secures-new-funding-to-support-key-inflection-points-and-pipeline-build 2024-10-06T20:44:01+11:00 http://pharmadispatch.com/news/new-drug-could-be-answer-to-an-overlooked-yet-devastating-type-of-dementia 2024-10-06T20:58:01+11:00 http://pharmadispatch.com/news/cyclopharm-sigs-agreement-makes-major-progress-with-us-veterans-and-defence-administrations 2024-10-06T21:10:01+11:00 http://pharmadispatch.com/news/csl-welcomes-new-treatment-for-high-risk-cardiovascular-disease-to-the-pbs 2024-10-07T14:00:01+11:00 http://pharmadispatch.com/news/chimeric-says-cancer-patient-achieves-complete-response-in-chm-core-nk-trial 2024-10-07T22:34:01+11:00 http://pharmadispatch.com/news/uq-spider-venom-heart-drug-moves-into-clinical-trials 2024-10-07T22:57:01+11:00 http://pharmadispatch.com/news/mark-butler-confirms-norgines-creation-of-dfmo-access-program 2024-10-08T00:53:01+11:00 http://pharmadispatch.com/news/new-report-reveals-significant-potential-return-from-investment-in-adult-vaccination 2024-10-08T14:00:01+11:00 http://pharmadispatch.com/news/anyone-wanting-to-know-how-this-might-work-look-to-new-zealand 2024-10-09T14:00:01+11:00 http://pharmadispatch.com/news/wesfarmers-health-releases-inaugural-wesfarmers-health-releases-australia-most-comprehensive-rea 2024-10-09T14:00:01+11:00 http://pharmadispatch.com/news/peak-bodies-align-in-consensus-statement-on-juvenile-arthritis 2024-10-09T14:00:01+11:00 http://pharmadispatch.com/news/medibank-expands-four-day-work-week-trial-to-500-employees 2024-10-09T20:53:01+11:00 http://pharmadispatch.com/news/tga-approves-new-indication-for-telixs-illuccix-to-include-patient-selection-for-psma-targeted-t 2024-10-09T21:13:01+11:00 http://pharmadispatch.com/news/amplia-therapeutics-ceo-shares-prime-ministers-prize-for-innovation 2024-10-10T14:00:01+11:00 http://pharmadispatch.com/news/healthy-bones-australia-calls-for-greater-government-commitment-to-bone-health 2024-10-09T23:52:01+11:00 http://pharmadispatch.com/news/new-report-unveils-hidden-cost-of-alzheimers-disease-with-cases-to-double-by-2050 2024-10-10T21:26:01+11:00 http://pharmadispatch.com/news/pharmac-announces-expanded-access-to-three-cancer-medicines 2024-10-11T14:00:01+11:00 http://pharmadispatch.com/news/bondi-junction-response-must-include-increased-funding-and-support-for-severe-mental-illness 2024-10-11T11:00:01+11:00 http://pharmadispatch.com/news/novartis-led-partnership-says-heart-health-shouldnt-be-dependent-on-where-you-live 2024-10-11T14:00:01+11:00 http://pharmadispatch.com/news/the-industry-faces-significant-uncertainty-with-barely-three-weeks-until-the-us-election 2024-10-14T14:00:01+11:00 http://pharmadispatch.com/news/tga-signs-memorandum-of-understanding-with-south-africas-regulator 2024-10-14T14:00:01+11:00 http://pharmadispatch.com/news/dementia-set-to-become-australias-leading-cause-of-death 2024-10-14T04:41:01+11:00 http://pharmadispatch.com/news/what-matters-is-whats-rational-for-the-industry-is-not-rational-for-the-government 2024-10-15T14:00:01+11:00 http://pharmadispatch.com/news/on-comparators-maybe-demand-the-return-of-a-policy-already-paid-for 2024-10-15T14:00:01+11:00 http://pharmadispatch.com/news/government-invests-more-in-preparation-for-new-avian-flu-strain 2024-10-15T02:05:01+11:00 http://pharmadispatch.com/news/funding-unapproved-copies-would-fundamentally-change-our-system-for-the-worst 2024-10-16T14:00:01+11:00 http://pharmadispatch.com/news/mark-butler-needs-to-understand-the-implications-of-accepting-this-recommendation 2024-10-16T02:48:01+11:00 http://pharmadispatch.com/news/ausbiotech-calling-on-experts-to-become-mentors-for-industry-growth-program 2024-10-16T07:14:01+11:00 http://pharmadispatch.com/news/this-has-happened-before-and-the-response-should-be-the-same-no 2024-10-17T14:00:01+11:00 http://pharmadispatch.com/news/vitalis-and-servita-partner-to-lead-healthcare-digital-transformation-in-queensland 2024-10-17T14:00:01+11:00 http://pharmadispatch.com/news/commercial-eyes-signs-new-service-agreement-with-opyl 2024-10-17T14:00:01+11:00 http://pharmadispatch.com/news/nyrada-says-it-has-completed-safety-studies-ahead-of-phase-1-clinical-trial 2024-10-17T01:03:01+11:00 http://pharmadispatch.com/news/trailblazers-speaks-with-leading-primary-care-leader-and-researcher 2024-10-17T14:00:01+11:00 http://pharmadispatch.com/news/biogen-awarded-great-place-to-work-certification-for-2024 2024-10-17T14:00:01+11:00 http://pharmadispatch.com/news/disappointment-for-eisai-as-tga-goes-public-early-on-alzheimers-therapy 2024-10-17T04:56:01+11:00 http://pharmadispatch.com/news/auditor-general-launches-audit-of-the-procurement-of-onshore-vaccine-manufacturing-facilities 2024-10-17T21:53:01+11:00 http://pharmadispatch.com/news/pharmac-seeking-bids-from-suppliers-for-covid-19-vaccines 2024-10-17T22:19:01+11:00 http://pharmadispatch.com/news/new-research-uncovers-australian-women-are-often-reluctant-to-openly-talk-about-menopause 2024-10-18T14:00:01+11:00 http://pharmadispatch.com/news/the-danger-of-this-outlier-is-reflected-in-the-disconnect-with-another-policy-process 2024-10-18T14:00:01+11:00 http://pharmadispatch.com/news/the-week-in-review-podcast-18-october 2024-10-19T00:42:01+11:00 http://pharmadispatch.com/news/only-those-not-confronting-a-life-ending-diagnosis-can-view-hope-as-intangible-and-false 2024-10-21T14:00:01+11:00 http://pharmadispatch.com/news/disappointment-in-response-to-status-quo-recommendation-on-new-process 2024-10-21T14:00:01+11:00 http://pharmadispatch.com/news/cancer-and-cushing-syndrome-therapies-secure-positive-recommendations 2024-10-21T14:00:01+11:00 http://pharmadispatch.com/news/us-fda-grants-rare-paediatric-designation-to-pycs-drug-development-program 2024-10-21T20:50:01+11:00 http://pharmadispatch.com/news/how-many-people-will-die-because-of-this-institutional-indifference 2024-10-22T14:00:01+11:00 http://pharmadispatch.com/news/australias-winter-report-card-the-impact-of-respiratory-illnesses-on-the-elderly-this-year 2024-10-22T12:00:01+11:00 http://pharmadispatch.com/news/alcon-supports-future-optometrists-through-new-educational-grant 2024-10-22T02:16:01+11:00 http://pharmadispatch.com/news/patients-groups-slam-pbacs-failure-on-streamlining-cancer-medicines-access 2024-10-22T14:00:01+11:00 http://pharmadispatch.com/news/our-job-as-advocates-is-to-interpret-what-patients-mean-by-hope-not-to-ignore-it 2024-10-23T14:00:01+11:00 http://pharmadispatch.com/news/the-dispatched-podcast-special-edition-1 2024-10-23T03:04:01+11:00 http://pharmadispatch.com/news/daiichi-sankyo-continues-australian-growth-trajectory 2024-10-23T14:00:01+11:00 http://pharmadispatch.com/news/companies-should-reject-the-letters-and-proceed-with-their-submissions 2024-10-23T21:10:01+11:00 http://pharmadispatch.com/news/this-has-happened-before-there-was-consultation-and-it-was-managed-without-harming-patients 2024-10-24T00:48:01+11:00 http://pharmadispatch.com/news/the-health-departments-strategy-is-based-on-the-hope-that-sponsors-do-not-submit 2024-10-24T14:00:01+11:00 http://pharmadispatch.com/news/health-department-attempts-to-defer-two-thirds-of-submissions-to-march-meetin 2024-10-24T14:00:01+11:00 http://pharmadispatch.com/news/release-of-white-paper-from-nzs-valuing-life-medicines-access-summit 2024-10-24T14:00:01+11:00 http://pharmadispatch.com/news/the-claim-the-pbac-has-the-power-to-set-its-meeting-agendas-is-utterly-false 2024-10-25T14:00:01+11:00 http://pharmadispatch.com/news/investigations-into-lung-cancer-and-into-recognised-with-csl-centenary-fellowships 2024-10-25T14:00:01+11:00 http://pharmadispatch.com/news/the-week-in-review-podcast-25-october 2024-10-25T05:40:01+11:00 http://pharmadispatch.com/news/health-department-officials-would-delighted-with-this-response 2024-10-28T14:01:01+11:00 http://pharmadispatch.com/news/an-odd-claim-given-what-it-anticipated-in-the-annual-cost-recovery-statement 2024-10-27T23:34:01+11:00 http://pharmadispatch.com/news/rheumagen-strengthens-leadership-with-appointment-of-top-industry-veterans 2024-10-28T01:08:01+11:00 http://pharmadispatch.com/news/ma-says-health-department-agree-to-consult-should-this-situation-occur-again 2024-10-28T14:00:01+11:00 http://pharmadispatch.com/news/decisions-taken-during-the-caretaker-period-are-governed-by-a-formal-convention 2024-10-29T14:00:01+11:00 http://pharmadispatch.com/news/australian-patients-association-announces-the-appointment-of-new-ceo 2024-10-28T06:11:01+11:00 http://pharmadispatch.com/news/when-the-government-says-prioritises-it-actually-means-deprioritising 2024-10-28T22:07:01+11:00 http://pharmadispatch.com/news/community-pharmacy-leads-nation-wide-transformation-of-womens-health-services 2024-10-29T14:00:01+11:00 http://pharmadispatch.com/news/nz-working-to-catch-up-as-bew-report-reveals-the-magnitude-of-the-challenge 2024-10-29T14:00:01+11:00 http://pharmadispatch.com/news/priceline-pharmacy-launches-a-refreshed-brand-strategy 2024-10-30T14:00:01+11:00 http://pharmadispatch.com/news/at-least-this-means-the-industry-will-never-again-take-lectures-on-these-issues 2024-10-29T23:43:01+11:00 http://pharmadispatch.com/news/vaccine-procurement-and-rollout-was-slow-but-did-reduce-the-number-of-deaths 2024-10-30T14:00:01+11:00 http://pharmadispatch.com/news/boehringer-ingelheim-leader-promoted-to-global-role 2024-10-30T14:00:01+11:00 http://pharmadispatch.com/news/annual-report-reveals-rebates-topped-5-billion-for-the-first-time 2024-11-01T01:00:01+11:00 http://pharmadispatch.com/news/amplia-announces-capital-raise-to-support-the-completion-of-phase-2a-accent-trial 2024-10-30T22:35:01+11:00 http://pharmadispatch.com/news/this-circular-and-semantic-argument-ends-with-one-conclusion-a-submission-cap 2024-10-31T14:00:01+11:00 http://pharmadispatch.com/news/this-would-be-the-most-significant-change-in-pbs-decision-making-in-over-30-years 2024-10-31T14:00:01+11:00 http://pharmadispatch.com/news/more-stakeholder-responses-to-covid-19-pandemic-response-inquiry 2024-10-31T03:35:01+11:00 http://pharmadispatch.com/news/it-has-been-both-challenging-and-rewarding-to-lead-medicines-australia 2024-10-31T06:44:01+11:00 http://pharmadispatch.com/news/liz-selby-goes-from-acting-to-permanent-head-of-sanofis-local-pharmaceutical-business 2024-11-01T14:00:01+11:00 http://pharmadispatch.com/news/arrotex-partners-with-juniper-to-deliver-new-rare-blood-cancer-treatment 2024-11-01T14:00:01+11:00 http://pharmadispatch.com/news/pharmac-proposes-expanding-access-to-amgens-osteoporosis-biologic 2024-11-01T14:00:01+11:00 http://pharmadispatch.com/news/the-week-in-review-podcast-1-november 2024-11-01T21:26:01+11:00 http://pharmadispatch.com/news/sometimes-the-industrys-duty-is-to-save-governments-from-stupid-decisions 2024-11-04T14:00:01+11:00 http://pharmadispatch.com/news/astrazeneca-opens-new-renewable-energy-project-in-macquaries-park 2024-11-04T14:00:01+11:00 http://pharmadispatch.com/news/patients-welcome-breakthrough-in-access-to-migraine-medications 2024-11-04T14:00:01+11:00 http://pharmadispatch.com/news/its-a-tricky-move-pretending-to-honour-the-election-commitment-to-medicines-access 2024-11-04T14:00:01+11:00 http://pharmadispatch.com/news/we-are-doing-something-that-most-people-think-is-impossible 2024-11-05T14:00:01+11:00 http://pharmadispatch.com/news/if-this-is-allowed-to-happen-the-broader-discussion-is-inevitable 2024-11-05T14:00:01+11:00 http://pharmadispatch.com/news/we-are-proud-to-have-been-certified-as-a-great-place-to-work-in-2024 2024-11-05T14:00:01+11:00 http://pharmadispatch.com/news/immugene-says-bile-tract-cancer-patient-maintains-complete-response-in-mast-study 2024-11-05T22:39:01+11:00 http://pharmadispatch.com/news/pharmac-minister-welcomes-accelerated-medsafe-approval-assessments 2024-11-06T02:16:01+11:00 http://pharmadispatch.com/news/scope-of-practice-final-report-triggers-debate-over-recommendations-for-reform 2024-11-06T14:00:01+11:00 http://pharmadispatch.com/news/the-relationship-between-hardened-language-and-outcome 2024-11-06T14:00:01+11:00 http://pharmadispatch.com/news/doctors-in-australia-lead-phase-3-theranostics-study-targeting-advanced-prostate-cancer 2024-11-06T21:53:01+11:00 http://pharmadispatch.com/news/pbac-instructed-to-meet-for-another-full-meeting-in-may 2024-11-06T22:30:01+11:00 http://pharmadispatch.com/news/the-solution-simply-gives-some-certainty-to-submissions-that-had-none 2024-11-07T15:00:01+11:00 http://pharmadispatch.com/news/rare-cancers-australia-set-to-launch-the-2025-kosi-challenge 2024-11-07T14:00:01+11:00 http://pharmadispatch.com/news/the-fight-is-not-over-until-this-is-all-resolved-but-seeing-the-system-start-to-move-is-a-great- 2024-11-07T14:00:01+11:00 http://pharmadispatch.com/news/ausbiotech-and-life-sciences-western-australia-fign-first-ever-mou 2024-11-07T17:09:01+11:00 http://pharmadispatch.com/news/officials-gauged-evaluator-capacity-after-the-minister-endorsed-their-plan 2024-11-08T03:57:01+11:00 http://pharmadispatch.com/news/lundbeck-announces-its-new-leadership-for-australia 2024-11-08T14:00:01+11:00 http://pharmadispatch.com/news/accc-will-not-oppose-sigma-chemist-warehouse-merger-subject-to-undertaking 2024-11-08T14:00:01+11:00 http://pharmadispatch.com/news/ausbiotech-and-mtpconnect-launch-joint-discussion-paper-on-life-science-growth-issues 2024-11-08T14:00:01+11:00 http://pharmadispatch.com/news/global-biosimilars-week-to-highlight-the-health-and-financial-benefits-of-biosimilar-medicines 2024-11-08T14:00:01+11:00 http://pharmadispatch.com/news/moderna-announces-the-awardees-for-its-2024-australia-fellowship-program 2024-11-11T14:00:01+11:00 http://pharmadispatch.com/news/mark-butler-announces-the-creation-of-hybrid-national-program-for-rsv-vaccine 2024-11-11T14:00:01+11:00 http://pharmadispatch.com/news/patients-win-when-health-ministers-do-what-they-are-elected-to-do 2024-11-11T14:00:01+11:00 http://pharmadispatch.com/news/pharmac-makes-cancer-therapy-the-26th-funded-since-budget-boost 2024-11-11T14:00:01+11:00 http://pharmadispatch.com/news/sandoz-celebrates-the-5th-annual-global-biosimilars-awareness-week 2024-11-12T15:53:01+11:00 http://pharmadispatch.com/news/the-pharmacy-guild-welcomes-free-rsv-vaccine-decision 2024-11-12T16:01:01+11:00 http://pharmadispatch.com/news/if-you-read-it-actually-its-a-cap-on-the-number-of-applications-that-can-be-considered-into-the- 2024-11-12T16:09:01+11:00 http://pharmadispatch.com/news/medical-device-sector-pushes-for-the-adoption-of-health-department-standards-charter 2024-11-12T14:00:01+11:00 http://pharmadispatch.com/news/data-shows-invasive-pneumococcal-disease-at-highest-level-in-15-years 2024-11-13T15:00:01+11:00 http://pharmadispatch.com/news/pharmac-to-fund-new-heart-medicine-for-18000-new-zealanders 2024-11-13T03:18:01+11:00 http://pharmadispatch.com/news/arthritis-experts-launch-the-atlas-arthritis-elearning-program-for-health-professionals 2024-11-13T14:00:01+11:00 http://pharmadispatch.com/news/ma-proposes-ceo-for-hta-review-implementation-group-and-wants-continuity 2024-11-14T14:00:01+11:00 http://pharmadispatch.com/news/any-approach-to-government-relations-based-on-the-montessori-method-is-doomed-to-fail 2024-11-14T14:00:01+11:00 http://pharmadispatch.com/news/ausbiotech-announces-the-inaugural-depaz-oration 2024-11-14T14:00:01+11:00 http://pharmadispatch.com/news/a-response-based-on-short-term-considerations-only-undermines-long-term-objectives 2024-11-15T14:00:01+11:00 http://pharmadispatch.com/news/a-procurement-mindset-must-not-impede-equitable-access-to-medicines-that-offer-significant-benef 2024-11-14T23:29:01+11:00 http://pharmadispatch.com/news/immutep-says-efti-insight-003-lung-cancer-trial-reveals-positive-survival-data 2024-11-15T02:23:01+11:00 http://pharmadispatch.com/news/botanix-expands-us-payer-coverage-for-sofdra-with-ascent-health-agreement 2024-11-15T03:46:01+11:00 http://pharmadispatch.com/news/amplia-enters-into-preclinical-collaboration-with-korean-drug-screening-company 2024-11-15T03:48:01+11:00 http://pharmadispatch.com/news/the-records-and-decisions-in-one-year-that-reverberate-to-this-day 2024-11-18T14:00:01+11:00 http://pharmadispatch.com/news/industry-gets-nervous-after-trump-appoints-rfk-jr-to-lead-us-health-and-human-services 2024-11-18T14:00:01+11:00 http://pharmadispatch.com/news/australian-companys-candidate-reduces-aggregation-of-key-als-disease-target 2024-11-18T03:33:01+11:00 http://pharmadispatch.com/news/ausbiotech-and-mtpconnect-bring-together-life-sciences-sector-for-national-summit 2024-11-19T14:00:01+11:00 http://pharmadispatch.com/news/clinuvel-announces-plan-to-prioritises-three-strategic-programs 2024-11-18T22:31:01+11:00 http://pharmadispatch.com/news/radiopharma-says-targeted-therapy-demonstrates-potential-for-pancreatic-cancer-patients 2024-11-18T22:46:01+11:00 http://pharmadispatch.com/news/tga-approves-modernas-updated-jn1-covid-19-vaccine 2024-11-18T23:06:01+11:00 http://pharmadispatch.com/news/bms-australia-to-host-a-summit-focused-on-patients-and-the-parliament 2024-11-19T14:00:01+11:00 http://pharmadispatch.com/news/pbac-member-and-former-industry-executive-appointed-to-board-of-local-biotech 2024-11-19T02:26:01+11:00 http://pharmadispatch.com/news/gbma-says-australia-can-benefit-from-a-biosimilar-medicines-funding-windfall 2024-11-20T14:00:01+11:00 http://pharmadispatch.com/news/moderna-appoints-new-director-of-regional-research-centre-for-respiratory-medicines-and-tropical 2024-11-20T00:28:01+11:00 http://pharmadispatch.com/news/ramsay-health-care-and-bupa-join-forces-to-develop-our-next-generation-of-nurses 2024-11-20T00:46:01+11:00 http://pharmadispatch.com/news/telix-announces-agreement-to-add-fap-targeting-candidates-to-theranostic-pipeline 2024-11-20T14:13:01+11:00 http://pharmadispatch.com/news/amgen-welcomes-expanded-listing-of-biologic-osteoporosis-therapy 2024-11-21T12:00:01+11:00 http://pharmadispatch.com/news/will-its-members-accept-the-same-operating-framework-that-dominated-the-reviews-reference-group 2024-11-20T22:30:01+11:00 http://pharmadispatch.com/news/nobody-better-qualified-to-make-a-difference-as-long-as-they-are-allowed-to 2024-11-21T12:00:01+11:00 http://pharmadispatch.com/news/pharmacy-guild-welcomes-new-qualification-for-the-profession 2024-11-21T13:27:01+11:00 http://pharmadispatch.com/news/medicines-australia-says-it-has-been-and-is-still-advocating-against-secrecy-provisions 2024-11-22T14:00:01+11:00 http://pharmadispatch.com/news/another-example-of-why-the-language-used-by-government-really-matters 2024-11-22T14:00:01+11:00 http://pharmadispatch.com/news/omicos-professor-david-thomas-receives-nsw-premiers-award-for-outstanding-cancer-researcher 2024-11-22T15:33:01+11:00 http://pharmadispatch.com/news/five-inspiring-australians-recognised-for-their-advocacy-support-and-care-for-people-living-with 2024-11-25T14:00:01+11:00 http://pharmadispatch.com/news/the-dispatched-podcast-22-november 2024-11-23T00:20:01+11:00 http://pharmadispatch.com/news/the-journey-of-a-word-from-high-level-principle-to-specific-policy-proposals 2024-11-25T14:00:01+11:00 http://pharmadispatch.com/news/stakeholders-deserve-clarity-on-the-strategic-objective-before-this-process-gets-underway 2024-11-25T14:00:01+11:00 http://pharmadispatch.com/news/the-comments-were-not-as-clear-but-they-clearly-frame-the-implementation-as-a-negotiation 2024-11-26T14:00:01+11:00 http://pharmadispatch.com/news/ge-healthcare-and-peter-maccallum-cancer-centre-partner-to-advance-cancer-research 2024-11-26T14:00:01+11:00 http://pharmadispatch.com/news/new-research-shows-confidence-robbing-condition-impacts-one-in-three-men-aged-over-40 2024-11-26T14:00:01+11:00 http://pharmadispatch.com/news/new-report-highlights-the-lack-of-research-on-climate-change-and-health-impacts 2024-11-26T21:42:01+11:00 http://pharmadispatch.com/news/senate-committee-to-question-pbac-chair-on-submission-deferrals 2024-11-27T14:00:01+11:00 http://pharmadispatch.com/news/organon-makes-the-move-from-macquarie-park-to-sydneys-cbd 2024-11-27T03:21:01+11:00 http://pharmadispatch.com/news/study-finds-popular-diabetes-and-obesity-drugs-also-protect-kidneys 2024-11-27T14:00:01+11:00 http://pharmadispatch.com/news/island-pharmaceuticals-says-isla-101-shows-anti-dengue-activity-in-phase-2a-study-readout 2024-11-27T23:03:01+11:00 http://pharmadispatch.com/news/medical-cannabis-company-montu-appoints-experienced-industry-executive-to-key-policy-and-advocac 2024-11-27T23:40:01+11:00 http://pharmadispatch.com/news/vaxxas-expands-global-ip-portfolio-for-exclusive-manufacture-and-sale-of-needle-free-vaccination 2024-11-27T23:51:01+11:00 http://pharmadispatch.com/news/australian-backed-triple-combination-hypertension-treatment-proceeding-to-regulatory-submission 2024-11-28T00:06:01+11:00 http://pharmadispatch.com/news/whooping-cough-cases-surge-across-australia-as-vaccination-rates-fall 2024-11-28T00:30:01+11:00 http://pharmadispatch.com/news/outgoing-president-proposes-dramatic-expansion-in-funded-access-to-weight-loss-therapies 2024-11-28T00:53:01+11:00 http://pharmadispatch.com/news/no-clarity-on-the-five-deferred-submissions-to-be-considered-at-march-pbac-meeting 2024-11-28T05:00:01+11:00 http://pharmadispatch.com/news/we-know-what-will-be-considered-in-march-but-not-what-has-been-pushed-to-may 2024-11-29T14:00:01+11:00 http://pharmadispatch.com/news/new-data-reveals-how-healthcare-professionals-can-support-communities-to-prepare-for-covid-19 2024-11-29T14:00:01+11:00 http://pharmadispatch.com/news/stakeholders-come-together-for-consensus-statement-in-support-of-bridging-fund 2024-11-29T14:00:01+11:00 http://pharmadispatch.com/news/the-week-in-review-podcast-29-november 2024-11-29T04:34:01+11:00 http://pharmadispatch.com/news/pbs-listing-for-australian-adults-living-with-adults-with-von-hippel-lindau-disease 2024-12-02T14:03:01+11:00 http://pharmadispatch.com/news/pbs-listing-of-bayers-endometriosis-treatment-breaks-30-year-drought 2024-12-02T14:00:01+11:00 http://pharmadispatch.com/news/publication-of-ministerial-advice-raises-questions-about-the-evidence-given-at-senate-estimates 2024-11-30T02:32:01+11:00 http://pharmadispatch.com/news/people-can-debate-whether-their-responses-constitute-misleading-the-senate 2024-12-02T14:00:01+11:00 http://pharmadispatch.com/news/nsw-government-backs-down-on-health-tax-in-new-agreement-with-health-funds 2024-12-02T21:26:01+11:00 http://pharmadispatch.com/news/4dmedical-signs-contract-to-expand-in-western-australia 2024-12-02T22:25:01+11:00 http://pharmadispatch.com/news/ausbiotech-welcomes-experienced-industry-executive-to-its-board 2024-12-02T22:33:01+11:00 http://pharmadispatch.com/news/orthocell-says-it-has-achieved-all-endpoints-in-pivotal-of-nerve-repair-product 2024-12-02T22:42:01+11:00 http://pharmadispatch.com/news/pharmac-minister-celebrates-increase-in-access-to-medicines-following-budget-boost 2024-12-03T03:13:01+11:00 http://pharmadispatch.com/news/brisbane-health-tech-unveils-advanced-manufacturing-facility 2024-12-03T03:22:01+11:00 http://pharmadispatch.com/news/albanese-government-launches-review-of-australias-research-and-development 2024-12-03T03:50:01+11:00 http://pharmadispatch.com/news/we-are-very-unhappy-that-we-were-not-consulted-as-it-is-an-expectation 2024-12-03T14:38:01+11:00 http://pharmadispatch.com/news/apparently-these-advisory-committees-know-thats-best-for-patients 2024-12-04T14:00:01+11:00 http://pharmadispatch.com/news/advisory-committees-less-than-enthusiastic-about-faster-patient-access-to-innovation 2024-12-04T14:00:01+11:00 http://pharmadispatch.com/news/pbac-supported-prioritising-submissions-in-its-response-to-hta-review 2024-12-04T14:00:01+11:00 http://pharmadispatch.com/news/half-of-australians-live-with-chronic-conditions-with-over-a-third-forced-to-leave-their-jobs-as 2024-12-04T14:00:01+11:00 http://pharmadispatch.com/news/moderna-opens-first-commercial-scale-mrna-manufacturing-facility-in-southern-hemisphere 2024-12-04T20:56:01+11:00 http://pharmadispatch.com/news/chatgpt-could-have-produced-a-more-human-response-than-these-committees 2024-12-05T14:00:01+11:00 http://pharmadispatch.com/news/greens-announce-plan-to-make-contraception-more-widely-accessible 2024-12-04T22:20:01+11:00 http://pharmadispatch.com/news/alterity-therapeutics-completes-last-patient-pisit-in-ath434-201-trial-in-multiple-system-atroph 2024-12-04T22:40:01+11:00 http://pharmadispatch.com/news/acrux-says-us-fda-approves-its-nitroglycerin-ointment-for-moderate-to-severe-pain 2024-12-04T22:49:01+11:00 http://pharmadispatch.com/news/london-agency-bolsters-public-affairs-team-with-crossbench-experience 2024-12-05T01:34:01+11:00 http://pharmadispatch.com/news/australians-rank-access-to-affordable-healthcare-as-second-most-important-priority-after-cost-of 2024-12-05T02:40:01+11:00 http://pharmadispatch.com/news/digital-health-company-adherium-secures-rd-loan-facility 2024-12-05T04:01:01+11:00 http://pharmadispatch.com/news/anatara-provides-irritable-bowel-syndrome-clinical-trial-update 2024-12-05T04:29:01+11:00 http://pharmadispatch.com/news/more-evidence-backs-use-of-weight-loss-therapies 2024-12-05T21:25:01+11:00 http://pharmadispatch.com/news/former-csl-ceo-paul-perreault-appointed-strategic-adviser-to-microbio 2024-12-05T22:23:01+11:00 http://pharmadispatch.com/news/novartis-partners-with-advara-heartcare-and-terrywhite-chemmart-to-launch-heart-health-collectiv 2024-12-06T14:00:01+11:00 http://pharmadispatch.com/news/pfizer-australia-launches-innovate-reconciliation-action-plan-to-advance-equitable-access-to-hea 2024-12-06T14:00:01+11:00 http://pharmadispatch.com/news/industry-executives-travel-to-florida-to-meet-with-incoming-trump-administration 2024-12-09T14:00:01+11:00 http://pharmadispatch.com/news/this-pbs-listing-is-a-major-shift-in-diabetes-management-in-australia 2024-12-08T14:00:01+11:00 http://pharmadispatch.com/news/if-this-is-the-mindset-at-what-point-does-the-question-become-why-fund-anything 2024-12-09T14:00:01+11:00 http://pharmadispatch.com/news/pharmac-invests-more-of-recent-funding-boost-with-astrazeneca-agreement 2024-12-08T11:00:01+11:00 http://pharmadispatch.com/news/paradigm-completes-16-million-capital-raise-to-support-global-phase-3-clinical-trial 2024-12-09T21:44:01+11:00 http://pharmadispatch.com/news/btc-announced-new-partnership-agreement-with-corcym 2024-12-09T21:53:01+11:00 http://pharmadispatch.com/news/recce-receives-approval-from-indonesias-regulator-for-registrational-phase-3-clinical-trial 2024-12-09T22:00:01+11:00 http://pharmadispatch.com/news/cyclopharm-says-furst-us-clinical-paper-highlights-technegas-clinical-effectiveness 2024-12-09T22:09:01+11:00 http://pharmadispatch.com/news/budget-update-will-reveal-spending-and-revenue-changes-including-for-the-pbs 2024-12-10T14:00:01+11:00 http://pharmadispatch.com/news/medtronic-leader-to-chair-medical-device-industry-association 2024-12-10T01:43:01+11:00 http://pharmadispatch.com/news/tga-approves-ucb-therapy-for-the-treatment-of-dravet-syndrome 2024-12-10T02:45:01+11:00 http://pharmadispatch.com/news/potential-australian-developed-treatment-for-mnd-shows-positive-early-trial-results 2024-12-10T05:43:01+11:00 http://pharmadispatch.com/news/welcome-and-encourage-these-workaround-because-they-expose-the-failing-institution 2024-12-11T14:00:01+11:00 http://pharmadispatch.com/news/pharmac-seeks-feedback-to-fund-medicines-for-liver-and-ovarian-cancer 2024-12-10T14:00:01+11:00 http://pharmadispatch.com/news/fivephusion-secures-resectassist-platform-technology-for-the-localised-delivery-of-cancer-drugs 2024-12-11T14:00:01+11:00 http://pharmadispatch.com/news/dhl-constructs-largest-automated-life-sciences-warehouse-footprint-in-the-southern-hemisphere 2024-12-11T21:19:01+11:00 http://pharmadispatch.com/news/what-could-the-hta-review-change-for-patients-who-waited-for-this-cancer-therapy 2024-12-12T14:00:01+11:00 http://pharmadispatch.com/news/health-groups-call-for-dying-patients-to-receive-free-pain-relief-amid-critical-medicines-shorta 2024-12-12T14:00:01+11:00 http://pharmadispatch.com/news/ausbiotech-and-biomelbourne-network-welcome-victorias-economic-growth-statement 2024-12-12T02:05:01+11:00 http://pharmadispatch.com/news/leafio-opens-sydney-distribution-facility-to-deliver-same-day-medical-cannabis-to-metro-pharmaci 2024-12-12T02:25:01+11:00 http://pharmadispatch.com/news/qimr-berghofer-says-cell-therapy-saving-lives-of-immunocompromised-patients 2024-12-12T04:46:01+11:00 http://pharmadispatch.com/news/immutep-reports-promising-new-data-in-head-and-neck-cancer-at-esmo-immuno-oncology-2024 2024-12-12T20:43:01+11:00 http://pharmadispatch.com/news/report-shows-that-weight-is-now-the-leading-risk-factor-for-australias-disease-burden 2024-12-13T14:00:01+11:00 http://pharmadispatch.com/news/this-process-has-involved-a-lot-of-work-for-everyone-and-delivered-almost-nothing 2024-12-13T02:38:01+11:00 http://pharmadispatch.com/news/medicines-australia-launches-pbs-explainer-videos 2024-12-13T04:37:01+11:00 http://pharmadispatch.com/news/racgp-calls-for-free-meningococcal-b-vaccination-program-for-western-australia 2024-12-13T04:51:01+11:00 http://pharmadispatch.com/news/the-week-in-review-podcast-13-december 2024-12-14T01:06:01+11:00 http://pharmadispatch.com/news/they-intended-to-launch-a-product-on-the-market-when-that-was-not-their-intention 2024-12-16T14:00:01+11:00 http://pharmadispatch.com/news/the-demand-has-been-higher-than-expected-and-weve-worked-hard-to-make-sure-that-it-remains-affor 2024-12-16T14:00:01+11:00 http://pharmadispatch.com/news/auditor-general-set-to-table-long-awaited-pbs-performance-audit 2024-12-15T21:33:01+11:00 http://pharmadispatch.com/news/immutep-and-monash-announce-first-publication-detailing-how-human-lag-3-binds-to-mhc-class-ii 2024-12-16T20:09:01+11:00 http://pharmadispatch.com/news/call-for-action-as-pneumococcal-outbreak-hits-20-year-high 2024-12-17T14:00:01+11:00 http://pharmadispatch.com/news/pyc-nominates-fourth-clinical-drug-candidate-in-phelan-mcdermid-program 2024-12-16T22:07:01+11:00 http://pharmadispatch.com/news/ausbiotech-and-bionsw-deepen-collaboration-with-new-mou 2024-12-17T04:00:01+11:00 http://pharmadispatch.com/news/australian-medtech-manufacturing-alliance-strengthens-with-new-steering-group-members 2024-12-17T05:06:01+11:00 http://pharmadispatch.com/news/auditor-general-finds-that-the-administration-of-the-is-partly-effective 2024-12-17T20:42:01+11:00 http://pharmadispatch.com/news/government-making-it-easier-for-itself-on-payments-but-patients-missing-out 2024-12-18T14:00:01+11:00 http://pharmadispatch.com/news/i-really-live-with-a-12-month-timeframeand-i-am-always-waiting 2024-12-18T03:34:01+11:00 http://pharmadispatch.com/news/australians-with-our-most-misunderstood-arthritis-receive-resources-in-time-for-holidays 2024-12-18T04:10:01+11:00 http://pharmadispatch.com/news/hta-implementation-group-waiting-for-ministerial-direction-on-priorities 2024-12-18T14:00:01+11:00 http://pharmadispatch.com/news/australias-first-mrna-vaccine-candidate-could-address-covid-immune-imprinting 2024-12-18T20:35:01+11:00 http://pharmadispatch.com/news/cartherics-secures-g-rex-grant-to-support-its-in-house-manufacturing-program 2024-12-18T21:07:01+11:00 http://pharmadispatch.com/news/if-you-have-ovarian-cancer-genomic-testing-may-open-up-new-treatment-option 2024-12-18T21:29:01+11:00 http://pharmadispatch.com/news/new-listings-and-higher-prescription-volumes-driving-pbs-spend 2024-12-18T21:57:01+11:00 http://pharmadispatch.com/news/race-oncology-appoints-opthea-founder-to-its-board 2024-12-18T22:26:01+11:00 http://pharmadispatch.com/news/when-the-government-funds-a-health-technology-the-community-makes-certain-assumptions 2024-12-19T14:00:01+11:00 http://pharmadispatch.com/news/if-this-decision-to-undermine-the-tga-reflects-a-policy-decision-be-transparent-about-it 2024-12-19T05:10:01+11:00 http://pharmadispatch.com/news/found-irregularities-and-anomalies-in-the-instruments-of-delegation-from-the-minister 2024-12-20T14:00:01+11:00 http://pharmadispatch.com/news/wholesalers-secure-agreement-with-government-to-secure-the-national-pbs-medicine-supply-chain 2024-12-20T06:19:01+11:00 http://pharmadispatch.com/news/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-vers 2024-12-20T06:33:01+11:00 http://pharmadispatch.com/news/companies-welcome-november-pbac-outcomes 2024-12-23T13:00:01+11:00 http://pharmadispatch.com/news/the-dispatched-podcast-this-draws-a-line-through-everything 2024-12-23T01:47:01+11:00